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SUMMARY XII
SUMMARY 
 
Members of the transforming growth factor (TGF)-β superfamily are key 
regulators of lung development and homeostasis, as well as alveolar epithelial cell 
function. TGF-β signalling involves ligand-dependent phosphorylation of receptor 
serine/threonine kinases, phosphorylation of pathway-specific transcription factors 
(Smads), nuclear translocation of Smads, and ultimately, modulation of gene 
expression. Although Smad-dependent responses represent the primary signalling 
system activated by TGF-β receptors, alternative signalling systems have recently 
been described, which also mediated TGF-β-induced effects. In this study, a 
proteomic approach was employed to identify: a) candidate proteins that are subjected 
to nuclear-cytoplasmic shuttling in response to TGF-β stimulation and b) novel 
proteins phosphorylated within TGF-β signaling pathway. In order to reduce 
complexity of the total proteome subcellular fractionation and phosphoproteome 
enrichment of A549 cells had been performed. Cytoplasmic, nuclear, and 
phosphoprotein enriched fractions were subjected to two dimensional polyacrylamide 
gel electrophoresis, tryptic digestion, and mass spectrometry in order to identify novel 
candidates/mediators of the TGF-β signaling pathway. In the first part of this study, a 
rapid increase of KHRSP, FUBP1, hnRNP-L, and hnRNP-H1 localization in the 
cytosol of A549 cells was observed, concomitant with a decrease in their nuclear 
localization after TGF-β stimulation. Proteomic data were confirmed by 
immunofluorescence and immunoblotting analyses. In the second part of this study, 
25 phosphoproteins were identified after TGF-β stimulation, 20 of them with different 
phosphorylation pattern in 2-DE and 5 of them without changes after TGF-β 
stimulation. In conclusion, we showed that proteomic approach can be used for 
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detecting novel intermediate proteins in signalling pathways and that regulatory 
functions of TGF-β signalling are broader than previously thought. 
 
ZUSAMMENFASSUNG XIV
ZUSAMMENFASSUNG 
 
 Mitglieder der TGF-β Familie stellen Schlüsselfaktoren für die Entwicklung 
und Homöostase der Lunge dar, sowie für die Funktion des alveolären Epithels. Die 
TGF-β Signalkaskade erfolgt durch ligandenabhängige Phosphorylierung von 
Rezeptor Serin/Threoninkinasen, anschließende Phosporylierung von spezifischen 
Transkriptionsfaktoren (Smads), die Translokation der Smads in den Nukleus und 
schließlich die Regulierung der Genexpression. Obwohl die smadabhängige 
Signaltransduktion das primäre Signalsystem darstellt, das durch TGF-β Rezeptoren 
aktiviert wird, wurden kürzlich auch andere Signalsysteme beschrieben, die ebenfalls 
durch TGF-β induzierte Effekte vermitteln. In der vorliegenden Studie nutzten wir 
einen proteomischen Ansatz um a) mögliche Proteine zu identifizieren, die als 
Reaktion auf TGF-β-Stimulation zwischen dem Nukleus und dem Zytoplasma 
pendeln und b) neue Proteine zu finden, die durch den TGF-β Signalweg 
phosphoryliert werden. Um die Komplexität des Proteoms zu reduzieren wurde eine 
subzelluläre Fraktionierung und eine Anreicherung der Phosphoproteine von A549 
Zellen durchgeführt. Mit den zytoplasmatischen, den nukleären und den 
Phosphoproteinfraktionen wurden jeweils zweidimensionale Polyacrylamid 
Gelelektrophoresen durchgeführt, anschließend eine Verdauung durch Trypsin und 
schließlich wurden mit Hilfe von Massenspektrometrie neue Kandidaten bzw. 
Mediatoren des TGF-β Signalweges identifiziert. Im ersten Teil der Studie wurde 
nach der TGF-β Stimulation ein rapider Anstieg von KHRSP, FUBP1, hnRNP-L und 
hnRNP-H1 im Zytosol der A549 Zellen beobachtet, einhergehend mit einer Abnahme 
dieser Proteine im Zellkern. Diese Daten wurden mit Hilfe von Immunfluoreszenz 
und Immunblots bestätigt. Im zweiten Teil der Studie wurden nach TGF-β 
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Stimulation 25 Phosphoproteine identifiziert, von denen 20 ein verändertes 
Phosphorylierungsmuster in der 2 dimensionalen Gelelektrophorese aufwiesen und 5 
Proteine keine Veränderung zeigten. Insgesamt zeigten wir, dass ein proteomischer 
Ansatz geeignet ist, um neue vermittelnde Proteine in Signaltransduktionswegen zu 
identifizieren und dass die regulatorischen Funktionen des TGF-β Signalweges 
umfassender sind als bisher angenommen.  
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1 INTRODUCTION 
 
General 
Transforming Growth Factor-β (TGF-β) signalling controls various cellular 
processes, including cell proliferation, recognition, differentiation, apoptosis, and 
specification of developmental fate during embryogesis as well as in mature tissues, 
in species ranging from flies, worms to mammals (Massague, 2000; Ten Dijke et al., 
2002). A TGF-β ligand initiates signalling by binding to and directing the 
dimerization of type I and type II receptor serine/threonine kinases on the cell surface. 
This allows the type II receptor to phosphorylate and activate the type I receptor 
kinase domain, which in turn transmit signals through phosphorylation of the 
intracellular Smad second messenger proteins.  
 
Figure 1.1. The canonical TGF-β Smad pathway. Transcription factors (Smads) require 
transforming growth factor-β to induce phosphorylation of receptor Smads (R-Smads) and direct their 
complex formation with the common Smad (co-Smad). To be accessible to membrane receptors, R-
Smads bind in the cytoplasm to proteins such as SARA (Smad anchor for receptor activation). 
Phosphorylation decreases the affinity of R-Smads for SARA, and increases binding affinity for the co-
Smad. Smad complex is free to move into the nucleus and associate with transcriptional coactivators or 
corepressors. The R-Smads that translocate into the nucleus can return to the cytoplasm, although their 
ubiquitination- and proteasome-dependent degradation in the nucleus is one of the ways to finish TGF-
β response (after Massague, 2000). 
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After activation, the Smad2 and Smad3 (R-Smads) form complexes with the common 
mediator Smad, Smad4. The complex then accumulate in the nucleus where they 
associate with cofactors and are directly involved in the transcriptional regulation of 
target genes. Via direct contact with the nuclear pore complex, Smad2 and Smad3 
undergo constant shuttling, providing a dynamic pool, which involves many 
cytoplasmic and nuclear signal transduction partners (Figure 1.1). Understanding 
covalent modifications of Smads and their regulation is essential for the in depth 
knowledge of their function. (Shu et al., 2004). 
The two major events in TGF-β signalling pathway are translocation and 
phosphorylation. In this study proteomic approach was used to elucidate novel 
intermediates in TGF-β signalling pathway.  
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1.1 TGF-β SIGNAL TRANSDUCTION 
1.1.1 The TGF-β superfamily of ligands 
Members of the TGF-β superfamily of ligands (Table 1) are synthesised as 
large precursor polypeptides that are later cleaved to generate mature, active ligands. 
Ligands are synthesised as 100 kDa pro-proteins which consist of an amino-terminal 
pro-region and a carboxy-terminal mature region (Gentry et al., 1988). The amino-
terminal facilitates dimerisation of the pro-proteins. Following dimerisation, the 
amino-terminal region are cleaved by endo-proteases at a conserved RXXR sequence 
(R, arginine; X, any amino acid residue) located upstream of the mature active 
domain of the TGF-β ligand (Kingsley, 1994). Another typical characteristic of most 
TGF-β family ligand members is the seven conserved cysteine residues in their 
mature region. 
Table 1. A network controlling a transforming growth factor-β signalling 
pathway  
 
TGF-β 
superfamily 
ligand 
Type II 
Receptor 
Type I 
Receptor R-Smads Co-Smad 
Ligand 
inhibitors 
Activin A Activin type II receptor 
Activin receptor 
like kinase 4 
Smad2 
Smad3 Smad4 Follistatin 
Growth 
differentiation 
factor 1 
Activin type II 
receptor 
Activin receptor 
like kinase 4 
Smad2 
Smad3 SmadS4  
Growth 
differentiation 
factor 11 
Activin type II-B 
receptor 
Activin receptor 
like kinase 4 
Smad2 
Smad3 Smad4  
Bone 
morphogenetic 
proteins 
Bone 
morphogenetic 
protein receptor 
II 
Activin receptor 
like kinase 3, 
Activin receptor 
like kinase 6 
Smad1 
Smad5 
Smad8 
Smad4 Noggin Chordin, DAN 
Nodal Activin type II-B receptor 
Activin receptor 
like kinase 4, 
Activin receptor 
like kinase 7 
Smad2 
Smad3 Smad4 
Activin, 
Lefty 
Transforming 
growth factor 
betas 
Transforming 
growth factor 
beta type II 
receptor 
Activin receptor 
like kinase 5 
Smad2 
Smad3 Smad4 
Latent 
transforming 
growth factor 
beta binding 
protein1, 
thrombospondin 
decorin 
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Six cysteine residue form a knot-like structure, whereas the residual cysteine, the 
fourth in the primary sequence, mediates binding of the two ligand monomers to one 
another, forming a dimer via a disulfide bond (Daopin et al., 1992) (Schlunegger and 
Grutter, 1992). The TGF-β superfamily of ligands consists of structurally-related 
proteins with molecular masses of approximately 25 kDa. Three mammalian genes 
encoding TGF-β ligand isoforms have been identified, TGF-β1 (Derynck et al., 
1985), TGF-β2 (de Martin et al., 1987) and TGF-β3 (Derynck et al., 1988). Different 
isoforms share 70-80% amino acid sequence identity and have similar activities. The 
difference in biological activity of the ligands are associated with the differential 
binding affinity to TGF-β receptors (Wrana et al., 1992) and to additional binding 
proteins including endoglin and betaglycan (Table 1). 
 
1.1.2 TGF-β signalling via serine/threonine kinase receptors 
Using a mutagenized lung epithelial cell line Mv1Lu resistant to TGF-β-induced 
growth inhibition it was demonstrated that only the type I and type II receptors were 
required for TGF-β signalling (Laiho et al., 1990). To date, seven type I and five type 
II receptors have been identified in mammals. The type I and type II receptors are 
structurally related to serine/threonine kinases, with highly conserved properties 
between the two subfamilies. These receptors are responsible for the binding of the 
TGF-β superfamily ligand members. All receptors contain non-homologous N-
glycosylated cysteine-rich extracellular domains, which participate in ligand binding. 
The ligand-binding extracellular domain is separated from the conserved 
serine/threonine kinase domain and carboxy-terminal tails with a single 
transmembrane domain (Derynck and Feng, 1997). The first type I receptors 
identified were activin receptor like kinase 1 and activin receptor like kinase 4 
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(ALK1-ALK4) (ten Dijke et al., 1993) and subsequently other type I receptors were 
identified, and were named according to specificity of their ligand-binding properties. 
All type I receptors (ALKs) have a molecular mass of 55-65 kDa and share several 
general structural motifs with the type II receptors. Similar to the type II receptors, the 
ALKs contain cysteine-rich extracellular domain with putative glycosylation sites, a 
short transmembrane region, and an intracellular serine/threonine kinase domain. In 
contrast to the type II receptors, the type I receptors contain a functionally important, 
highly conserved, ~30 amino acid long glycine/serine (G/S) rich region with a 
consensus SGSGSG sequence, called as GS-box. The GS-box is important for the 
activation of type I receptors. The C-terminal intracellular regions of the ALKs are 
also substantially shorter than those of the type II receptors (Massague, 1998). The 
five type II receptors consist of approximately 500 amino acids, the molecular masses 
of which vary between 75-85kDa. The type II receptor, represent by TβRII, is 
constitutively phosphorylated at several serine residues and ligand-binding does not 
affect its phosphorylation status (Luo and Lodish, 1997).  
However, upon ligand binding, a tetrameric complex containing two type I and two 
type II receptors is formed, and the constitutively active type II receptor then 
transphophorylates the type I receptor at several serine and threonine residues in its 
GS-box (Chen et al., 1997; Wieser et al., 1995). 
 
1.1.3 Intracellular signalling molecules 
1.1.3.1 Smads 
Smads are the only by far known direct substrates of type I TGF-β receptors 
with a signalling function. They were first identified in Drosophila as Mad and C. 
elegans as Sma genes, which lie downstream of the BMP ligand-receptor systems in 
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these organisms. The human genome encodes eight Smad family members [Mad-
homologues (MADH)] and homologue of Smads are also known to be present in rat, 
mouse, Xenopus, zebrafish, the helminth Schistosoma mansoni besideDrosophila and 
C. elegans (Moustakas et al., 2001). Smads are expressed throughout development: 
embryogenesis and in all adult tissues. Many of them (Smad2, Smad4, Smad5, Smad6 
and Smad8) are produced from alternatively spliced mRNAs (Gene encyclopaedia, 
GeneCards) (Figure 1.2). 
 
Figure 1.2. Structure of R-Smads, Smad4 and I-Smads (Smad6 und Smad7) The MH1 (dark pink) 
and MH2 (cyan) domains are conserved between Smads. The motifs shown are the β10-strand (dark 
blue), α-helix 2 (red), β-strands 8 and 9 (β8/9, red), L3 loop (L3, green), α-helix 5 (H5, brown), and 
pSXpS, the phosphorylated C-terminal SxS motif of the R-Smads (black). The MH1 domain of Smad3 
and Smad4 binds DNA. Both the MH1 and the MH2 domain interact with other transcription factors. 
FM, Fast or FoxH1 motif; MH, Mad homology; NES, nuclear export signal; NLS, nuclear localization 
signal; NUPs, nucleoporins; PY, the PPxY motif that mediates binding to Smurf1 and Smurf2; SAD, 
Smad activation domain; SIM, Smad interaction motif (after P. ten Dijke and CS. Hill, 2004). 
 
Functionally, Smads can be divided into three subfamilies: 
1. Receptor-activated Smads (R-Smads: Smad1, Smad2, Smad3, Smad5, Smad8), 
which are phosphorylated by the type I receptors;  
2. Common mediator Smads (Co-Smad: Smad4), which oligomerise with activated R-
Smads.  
3. Inhibitory Smads (I-Smads: Smad6 and Smad7), which are induced by TGF-β  
family members. Both Smad6 and Smad7 exert a negative feedback effect by 
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competing with R-Smads for receptor interaction and by marking the receptors for 
degradation (Moustakas et al., 2001). 
Smads have two conserved domains, the N-terminal Mad homology 1 (MH1) and C-
terminal Mad homology 2 (MH2) domains (Figure 1.2). The MH1 domain is highly 
conserved among R-Smads and Co-Smads; the N-terminal regions of I-Smads have 
only weak sequence similarity to MH1 domains. Sequence and structural analyses 
indicated that the MH1 domain is homologous to the diverse histidine-metal-ion (His-
Me) finger family of endonucleases. The MH1 domain regulates nuclear import and 
transcription by binding to DNA and interacting with nuclear proteins (Reguly and 
Wrana, 2003). The MH2 domain is also highly conserved between all Smads, 
containing several α-helices and loops which surround a β-sandwich structure, 
resembling the forkhead associated (FHA) domain, a phosphopeptide-binding domain 
common in transcription and signalling factors (Shi, 2001). The MH2 domain 
regulates Smad oligomerisation, recognition by type I receptors, and interacts with 
cytoplasmic adaptors and several transcription factors (Moustakas et al., 2001). 
 
1.1.3.2 Smad phosphorylation and dephosphorylation 
The TGF-β receptor-induced phosphorylation of the C-terminal SXS motif of 
R-Smads is the signal for interaction with Smad4. The complex accumulates in the 
nucleus and binds to transcription factors and DNA to modulate gene transcription. 
The identities of Smad phosphatases however remain under investigation. Smad 
phosphatases can act either in the cytoplasm to limit the amount of phosphorylated R-
Smads that enter the nucleus or they can act inside the nucleus to terminate the 
transcriptional regulation by R-Smads because dephosphorylation of R-Smads is 
required for nuclear export of R-Smads and Smad4 (Inman et al., 2002; Xu et al., 
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2002). Recently, an RNAi screen of Ser/Thr phosphatases in cultured Drosphilia S2 
cells identified PDP (Pyruvate Dehydrogenase Phosphatase) as a Smad phosphatase 
(Chen et al., 2006). In has been demonstrated that PPM1A (protein phosphatase 1A 
magnesium-dependent, alpha isoform) can dephosphorylate Smad2 and Smad3. This 
phosphatase is predominantly localized in the nucleus and its activity facilitates 
nuclear export of Smad2/3 (Lin et al., 2006). It has been reported that the Small C-
terminal Domain Phosphatases (SCP) dephosphorylate Smad1 and subsequently 
increase transcriptional activation of target genes in response to BMP (Knockaert et 
al., 2006). Dephosphorylation studies on Smads may yield a new insight into 
downregulation of TGF-β signalling, which is an important mechanism of regulation 
of this pathway. 
1.1.3.2.1 Smad phosphorylation by other pathways 
In addition to phosphorylation of R-Smads by TGF-β, phosphorylation of 
endogenous R-Smads can be undertaken by other pathways as well. These 
phosphorylations are induced by different extracellular signals and the targeted sites 
are primarily localized in the N-terminal linker region of Smads. The mitogen 
activated protein kinase (MAPKs) can phosphorylate Smad1 upon epidermal growth 
factor (EGF) stimulation (Kretzschmar et al., 1997). Phosphorylation of Smad2, 
Smad3 and Smad4 by MAPKs has been also reported (Javelaud and Mauviel, 2005). 
The linker region of Smad2 and Smad3 is subjected to phosphorylation by calmodulin 
dependent protein kinase II (CaMKII); the N-terminal and linker regions of Smad3 
have been shown to be phosphorylated by cyclin dependent kinases (CDKs), which 
are regulated in a cell-cycle-dependent manner (Matsuura et al., 2004). The G protein-
coupled receptor kinase 2 (GRK-2) mediated phosphorylation of Ser197 in Smad2, 
inhibited the carboxy-terminal phosphorylation in response to TGF-β, thereby 
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preventing nuclear accumulation of Smad2 (Ho et al., 2005). Both MAPK- and 
CaMKII-mediated phosphorylation does not interfere with the carboxy-terminal 
phosphorylation of R-Smads by TGF-β or BMP receptor kinases, but in turn it was 
shown to inhibit nuclear accumulation of Smad1, Smad2, and Smad3 (Kretzschmar et 
al., 1997). The N-terminal and linker phosphorylation of Smads by CDKs resulted in 
a reduced transcriptional activation potency of Smad3. Whether this was due to a 
decreased interaction of Smad3 with transcription co-factors remains to be tested, but 
there is no apparent effect on the carboxy-terminal phosphorylation of Smad3. 
1.1.3.3 Nucleocytoplasmic Smad Shuttling 
Smads constantly shuttle between the cytoplasm and the nucleus. They can 
shuttled both in an uninduced state and during stimulation with TGF-β superfamily 
ligands (Inman et al., 2002; Xu et al., 2002). In uninduced cells, Smad2 and Smad3 
are primarily cytoplasmic, and Smad4 is dispersed throughout the nucleus and 
cytoplasm (Figure 1.3) (Pierreux et al., 2000; Watanabe et al., 2000; Xu et al., 2002). 
Receptor-regulated Smads (R-Smads) require TGF-β induced phosphorylation to 
form transcription regulatory complexes with partner Smads. In order to be accessible 
for membrane receptors, R-Smads are found in a complex with accession, proteins 
including SARA (Smad anchor for receptor activation). The R-Smad phosphorylation 
decreases the affinity of R-Smads for SARA, and increases their affinity for the co-
Smad. The Smad complex is free to move into the nucleus and can form complex with 
transcriptional coactivators or corepressors. The R-Smads that move into the nucleus 
may return to the cytoplasm. Their ubiquitylation and proteasome-dependent 
degradation in the nucleus provide means of termination TGF-β responses (Massague, 
2000). However, the nucleocytoplasmic shuttling of Smads and its regulation has not 
been completely resolved. Studies by Xu and Massague (Xu et al., 2003; Xu et al., 
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2000; Xu et al., 2002) have suggested that Smad nucleocytoplasmic shuttling is 
independent of the transport of receptors, and is mediated only through direct 
interactions with nucleoporins, primarily Nup214 and Nup153. Smad interactions 
with the nuclear pore appear to be independent of their phosphorylation state and 
whether they are monomeric or oligomeric (ten Dijke and Hill, 2004). 
. 
 
Figure 1.3. Model of nucleocytoplasmic shuttling of Smads. Smad proteins shuttle between the 
cytoplasm and nucleus both in uninduced cells and in cells stimulated with TGF-β superfamily ligands. 
In active signalling, continuous Smad shuttling provides a mechanism whereby intracellular 
transducers can monitor receptor activity. Export of Smad4 (purple) is mediated by CRM1 (ten Dijke 
and Hill, 2004). 
 
The monomeric Smads (R-Smads) have a higher affinity for cytoplasmic retention 
factors like SARA. Complexed Smads have a higher affinity for nuclear retention 
factors such as transcription factors and DNA (Xu et al., 2003; Xu et al., 2002). This 
model might explain the cytoplasmic localization of Smads in unstimulated cells and 
their accumulation in the nucleus after TGF-β treatment. An alternative model 
proposes the localization of Smads in given situation as a function of relative rates of 
import and export: monomeric Smads are predominantly exported from the nucleus, 
while complexed Smads are rather imported. Complex formation might either 
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stimulate import or inhibit export (Kurisaki et al., 2001; Watanabe et al., 2000). 
Mechanisms of nucleocytoplasmic shuttling of Smads in the TGF-β pathway deserve 
further examination. In addition, since the TGF-β pathway provides an excess of 
interacting signalling factors, proteomic screens could help to revel the complete 
repertoire of proteins that undergo nucleocytoplasmic shuttling. 
 
1.2 NEGATIVE REGULATION OF TGF-β SIGNALLING  
1.2.1 Inhibitor Smads 
The I-Smads (Smad6 and Smad7) are the inhibitors of TGF-β induced Smad 
mediated signalling. The MH2 domain of the I-Smads is structurally related to the R-
Smads and co-Smads but their N-terminal region is highly different from other Smads 
(Figure 1.2). The I-Smads do not have the SSXS domain and according to Miyazono 
et. al. (Miyazono et al., 2003) this allows them to stably bind to the activated type I 
receptor. The expression of I-Smads is upregulated after activation of R-Smads, most 
likely in order to prevent excessive stimulation of the cell, therefore I-Smads form a 
negative feedback loop (Miyazono, 2002). 
Smad6 appears to be an antagonist of BMP signalling, while Smad7 can 
shown to antagonise signalling by TGF-β and activin (Liu et al., 2002). The I-Smad 
interference with the Smad signalling pathways exist on two levels: binding and 
formation of R-Smad-Smad4 complex. Overexpression of I-Smads blocks Smad 
signalling by binding to the R-Smad-type I receptor interaction site or through their 
MH2 domains, (Imamura et al., 1997). At lower expression levels, Smad6 competes 
with Smad4 for binding to R-Smads, which blocks the formation of R-Smad-Smad4 
complexes. 
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1.2.2 Smad ubiquitination 
Negative regulation of TGF-β signalling can also occur through degradation of 
R-Smads by the ubiquitin-proteosome system. Proteosomal degradation of Smads is 
assisted by Smad-mediated ubiquitin regulatory factors (Smurfs, Smurf1 and Smurf2). 
Smurf1 induces ubiquitination and later degradation of the BMP-specific Smad1 and 
Smad5 by binding to the PPXY motif in their linker region (Zhu et al., 1999). Smurf2 
associates with Smad1 and Smad2, and targets them for degradation (Lin et al., 2000; 
Zhang et al., 2001). Smad4 lacks a PPXY motif to engage the Smurfs. Recently 
Dupont et al. (Dupont et al., 2005) reported the suppression of Smad4 functions by 
ectodermin/TIF1-γ, a protein harboring a RING domain in addition to a number of 
other functional domains, and thus acting as Smurfs for R-Smads .  
 
1.3 SMAD-INDEPENDENT SIGNALING CASCADES ACTIVATED BY 
TGF-β FAMILY MEMBERS 
Prior to the discovery of the canonical TGF-β signalling pathway, the small 
GTPase Ras and the mitogen-activated protein kinases (MAPKs; ERK, p38 and c-Jun 
N-terminal kinase (JNK)) were implicated in TGF-β signalling (Yue and Mulder, 
2000). The TGF-β type II receptor interacts with the proapoptotic adaptor protein 
Daxx, which leads to activation of JNK and induction the of apoptosis in epithelial 
cells and hepatocytes (Perlman et al., 2001). Furthermore, TGF-β signalling in 
cultured rat articular chondrocytes (CRAC) is regulated by protein kinase A (PKA) 
and protein kinase C (PKC) (Hirota et al., 2000). Genetic evidence in normal 
mammary epithelial cells stably-transfected with a mutant type I TGF-β receptor that 
cannot bind and thus activate R-Smads, implicated the p38 and JNK pathways in 
mammary cell apoptosis (Itoh et al., 2003; Yu et al., 2002). The type I receptor kinase 
activates the p38 and JNK pathways indepently of other factors (including Smads) 
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that bind to the receptor. Biological responses to TGF-β depend on a balance between 
multiple signalling pathways, each activated in a cell-type and context-dependent 
manner, involving both Smad-dependent and Smad-independent pathways (Derynck 
and Zhang, 2003). 
 
1.4 TGF- β SIGNALLING IN HUMAN DISORDERS 
1.4.1 Idiopathic pulmonary fibrosis 
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrotic lung 
disease of unknown etiology. Histologically, the lung is characterised by temporally 
heterogeneous lesions where normal lung is interspersed with areas of fibrosis, 
aggregates of fibroblasts called fibroblast foci and enlarged distorted airspaces called 
honeycomb cysts (Gross and Hunninghake, 2001; Khalil et al., 2001). It has been 
demonstrated that epithelial cells express a number of fibrogenic cytokines, such as 
TGF-β, platelet-derived growth factor (PDGF) (Antoniades et al., 1990), interleukin-1 
(IL-1) and tumor necrosis factor alpha (TNF-α) (Nash et al., 1993; Pan et al., 1996). 
Data from patients with IPF and animal models of this disease support the idea that 
TGF-β is a key player involved in the development of IPF. It has been shown that 
macrophages and lavage fluid from patients with IPF contain large amounts of TGF-
β. The presence of TGF-β in fibroblastic foci was also demonstrated in biopsies from 
patients with IPF. Gene expression studies in human tissue show obvious up-
regulation of TGF-β-responsive genes in IPF (Kaminski et al., 2000). Furthermore, 
transgenic mice overexpressing TGF-β and overexpression models of TGF-β have 
demonstrated that the presence of this cytokine alone is sufficient to induce a 
progressive fibrotic response independent of inflammation (Zhang et al., 2004), (Lee 
et al., 2004), thereby demonstrating important role of TGF-β in IPF. 
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1.4.2 Other disorders 
The anti-mitogenic tumor suppressive effect of TGF-β is lost in several tumor-
derived cell lines, and it has been proposed that mutations in the TGF-β signalling 
cascade are involved in a large fraction of pancreatic and colorectal cancers (de 
Caestecker et al., 2000). Inactivating mutations in genes encoding the TGF-β type II 
receptors have been detected in colorectal and gastric cancers (Luo and Lodish, 1997). 
Furthermore, gene encoding serine/threonine kinase receptors are also found to be 
mutated in some hereditary pre-malignant syndromes. Mutations in ALK3 have been 
shown to be responsible for variants of juvenile polypotic syndromes, where an 
affected individual are at a high risk for the development of malignant tumors from 
pre-existing benign polyps. Mutations in the gene encoding Smad2 or deletions have 
been reported in several cancers, including colorectal, lung and helatocellular. The 
chromosomal region where Smad4 is located is deleted in more than 50% of human 
pancreatic carcinomas (Blobe et al., 2000). In addition, mutations in the gene 
encoding Smad4 have been studied in ovarian, prostate, pancreatic and colorectal 
cancers. Mutations in the gene encoding ALK1 cause hereditary haemorrhagic 
telangiectasia (HHT) type 2, and mutations in endoglin, an accessory TGF-β receptor 
cause hereditary haemorrhagic telangiectasia type 1 (a TGF-β type III receptor) 
(Blobe et al., 2000). Similary mutations in the gene encoding BMPRII may cause the 
rare autosomal dominant genetic disorder familial pulmonary arterial hypertension 
(FPAH).  
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1.5 PROTEOMICS 
General  
The term proteomics encompass studies on proteins, particularly their 
structure and function, as well as identification and localization studies of proteins 
and interaction studies using different methods like two dimensional gel 
electrophoresis and mass spectrometry, immunochistochemistry, immunoprecipitation 
or the yeast two-hybrid system (Pandey and Mann, 2000). 
The Figure 1.4 presents a one of the proteomic approaches, which includes the 
separation of the proteome by two-dimensional gel electrophoresis and identification 
of proteins or polypeptides from a gel using mass spectrometry. Different subcellular 
compartments contain different amount of proteins in order to provide suitable 
biochemical environments for their particular function. The identification of proteins 
and their subcellular localization is, an important initial step for the understanding of 
cellular function (Dreger, 2003b). 
 
 
Figure 1.4. General proteome analysis using two-dimensional gel electrophoresis and mass 
spectrometry. 
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1.5.1 Subcellular proteomics 
Proteins within the cell are able to shuttle between membrane receptors, the 
cytoplasm and nucleus (Dreger, 2003b). Two dimensional electrophoresis (2-DE) has 
exceptional analytical power to separate large number of proteins. There are certain 
classes of proteins like phosphoproteins or proteins which are major constituent of 
specific cellular compartments and in complete crude homogenate they might not be 
detected on 2-DE gel (Mann et al., 2002). The classic approach may fail in the 
discovery of novel proteins, which undergo cytoplasmic/nuclear shuttling. Performing 
proteomic analysis at a subcellular level is therefore an appropriate strategy for this 
kind of study (Dreger, 2003a). 
1.5.2 Phosphoproteomics 
The primary aim of signal transduction is the spread and amplification of 
signals from membrane receptors to the nucleus. One major stream of information is 
mediated through reversible phosphorylation of proteins (Pawson and Scott, 1997) 
(Hunter et al., 1985). In eukaryotes, phosphorylation occurs mainly on serine, 
threonine, and tyrosine residues. Phosphorylation on serine and threonine residues is 
more abundant than on tyrosine residues. The phosphoserine: phosphothreonine: 
phosphotyrosine ratio is 1800:200:1 in vertebrates (Hunter and Cooper, 1985). The 
degree of phosphorylation is regulated by the interplay between the activities of 
protein kinases and protein phosphatases. 
The TGF-β ligand signal via receptor serine/threonine kinases and intracellular Smad 
molecules. Several intracellular proteins that mediate signalling by receptor tyrosine 
kinases, G protein-coupled receptor or cytokine receptors also participate in TGF-β 
signalling (Javelaud and Mauviel, 2005). Some previous studies combined 
immunoprecipitation (IP) with anti-phosphorylation antibody and SDS-PAGE or two 
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dimensional electrophoresis (2-DE) and mass spectrometry (MS) to reveal epidermal 
growth factor receptor, interferon receptor-α, interleukin-2, MAPK and fibroblast 
growth factor signalling pathways (Steen et al., 2002), (Pandey et al., 2000), (Hinsby 
et al., 2003). Immunoprecipitation of phosphotyrosine containing proteins (Mann et 
al., 2002) is still much more frequent than immunoprecipitation using mixtures of 
phosphoserine or threonine antibodies (Gronborg et al., 2002). Up to date, specific 
antibodies for serine/threonine phosphorylation are not available. Enrichment of 
phosphorylated proteins and/or peptides followed by mass spectrometry is possibly 
the most widely-used approach in elucidating signaling by receptor serine/threonine 
kinases (Kalume et al., 2003). 
1.5.2.1 Immobilized metal-ion affinity chromatography: enrichment of  
phosphoproteins 
Immobilized metal-ion affinity chromatography (IMAC) was first introduced 
by Porath et al. (Porath et al., 1975) for the purification of His-tagged proteins. At 
present, it is used primarily for the enrichment and purification of phosphopeptide 
(McLachlin and Chait, 2001). Phosphorylated peptides and proteins are bound to the 
stationary phase by electrostatic interactions with positively charged metal-ions, such 
as Fe3+, Ga3+, Al3+, Zr4+, Ti4+  that are bound to the column material via iminodiacetic 
acid (IDA), nitriloacetic acid (NTA) or tris-(carboxymethyl)-ethylendiamine (TED) 
linkers (Liu et al., 2003; Nuhse et al., 2003). Non-phosphorylated species are removed 
in the flowthrough, and the phosphopeptides and/or proteins may be eluted by salt-
and/or pH-gradients. In this way, multiple phosphorylated peptides or proteins are 
enriched, as a very acidic peptides that are bound to the column (Stensballe et al., 
2001). Nevertheless, reaction conditions have to be chosen with care to avoid 
incomplete esterification and side reactions, for instance on asparagines, in order to 
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avoid increased sample complexity which would interfere with mass spectrometry 
analysis. The IMAC technology is described to be compatible with following 
separation and detection techniques like capillary electrophoresis (CE), (Cao and 
Stults, 1999), LC-MS/MS (Heintz et al., 2004) and direct MALDI-MS of 
phosphopeptides bound to IMAC beads on the target (Reinders and Sickmann, 2005). 
1.5.3 Two dimensional gel electrophoresis 
Two dimensional gel electrophoresis (2-DE) combines isoelectric focusing 
(IEF) in the first dimension, which facilitates the separation of very complex mixtures 
of proteins or polypeptides according to their isoelectric point (pI) and by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) in the second 
dimension, where separation of complex mixtures is performed according to 
molecular weight (MW). 2-DE can be used to separate more than 5000 proteins 
simultaneously, and can detect less than 1 ng of protein per spot and later used for 
identification by mass spectrometry (Gorg et al., 2004). To date, this is only method 
which facilitate the study of intact proteins, isoforms or post-translational 
modifications (PTM) at a global basis. 
1.5.4 Protein detection and quantitation 
After 2-DE, the separated proteins have to be visualized, either by universal 
(coomassie blue or silver staining) or by specific staining methods. The right selection 
of visualization method is one of most important steps in the assays, which will be 
followed by quantification. Therefore, the method should be of high sensitivity, high 
linear dynamic range (for quantitative accuracy), reproducibility, and compatibility 
with identification procedures, for example fluorescent stainer SyproRuby. Already, 
mentioned universal staining methods are coomassie blue (anionic dyes staining), but 
only in case of having enough sample (detection limits 100ng); silver staining method 
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is a very sensitive one, although this procedure does not have high linear dynamic 
range. Fluorescence staining or labelling is employed mostly because of its very high 
sensitivity, quantification possibilities and subsequently sample can be applied to 
mass spectrometry (Corthals et al., 2000). The dynamic range of quatitation obtained 
with fluorescent stains matches the dynamic range of protein expression levels 
measured in yeast (Velculescu et al., 1997). 
A widely used fluorescence based visualization method is SyproRuby, a ruthenium 
complex bind robustly to proteins like a Coomassie Brilliant Blue-type mechanism, 
involving lysine, arginine and histidine residues (Berggren et al., 2000). This 
fluorescence stain can be visualized by commonly-used image analysis systems, and 
the dye maximally emits signall at about 610 nm (Berggren et al., 1999; Patton, 
2000). 
After enrichment of phosphoproteins and separating by different analytical methods, 
they can be visualized either directly in 2-DE gels using phosphospecific stains 
(Cutting and Roth, 1973; Patton, 2002) or using one dimensional electrophoresis 
followed by western blotting techniques (Kaufmann et al., 2001). The radioactive 
labelling is still the most sensitive detection method by 32P or 33P, followed by 
autoradiography (Bendt et al., 2003; Hathaway and Haeberle, 1985). Commercially 
available phosphospecific-stains, for example Pro-Q Diamond, are less sensitive than 
radioactive methods but the use of these “inactive” reagents is far more safe 
(Steinberg et al., 2003; Valles et al., 2003). The good compatibility of these staining 
methods and mass spectrometry has been reported in many studies for identification 
of phosphoproteins without additional assays like immunoblotting. 
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1.5.5  Protein identification and characterization 
1.5.5.1 Mass spectrometry and protein analysis 
One of the major advancement in proteomics to date so far has been the mass 
spectrometric identification of proteins separated by SDS-PAGE. Since eightie´s mass 
spectrometry has replaced the more classical Edman degradation, since it is much 
more sensitive, can be used with protein mixtures, has a much higher throughput 
applicability (Mann et al., 2002). Mass spectrometry use a peptide or several peptides 
to identify a protein, where peptides have been derived from digestion of a protein 
with one or more proteases. Only a few peptides are required in order to identify 
protein (Rappsilber and Mann, 2002). 
Prior to detection and analysis, peptides must be ionised and later fragmentated to 
single amino acids. Fragmentation fingerprints can be used for identification by 
comparison with fragment databases, which are available online. Complex mixtures 
can be analysed with coupling of mass spectrometers with different separation 
methods like gas chromatography-mass spectrometry (GC-MS) and high preassured 
liquid chromatography-mass spectormetry (HPLC-MS) or capillary electrophoresis 
(CE-MS) (Pandey and Mann, 2000). 
1.5.5.2 Matrix assisted laser desorption/ionization 
  Many different mass spectrometers are available on the market, each consist of 
an ion source, a mass analyser that measures the mass-to-charge ratio (m/z) of the 
ionised analytes and a detector that registers the number of ions at each m/z value. 
Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI) are the two techniques most commonly used to ionise proteins or peptides 
for mass spectrometric analysis (Karas and Hillenkamp, 1988). First reports about use 
of MALDI come form group of Hillenkamp in 1988 (Karas and Hillenkamp, 1988), 
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where sample was applied on a crystalline matrix and MALDI sublimed and ionises 
the samples with laser pulses . One of the frequently used analysers in MALDI mass 
spectrometers is the time of flight mass analyser (TOF). The MALDI-TOF 
methodology is used to identify many compounds including sugers, lipids, nucleic 
acids and proteins. Identification of proteins is known as peptide mass fingerprinting. 
Proteins are identified by matching a list of experimental peptide masses with the 
calculated list of all peptide masses of each entry in a database. Peptide mass mapping 
by MALDI-TOF has become very efficient at the identification of gel-separated 
proteins (Aebersold and Mann, 2003).  
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2 AIM OF THE STUDY 
 
There are two major events in TGF-β signal transduction: a) constant shuttling 
between the cytoplasm and nucleus of the downstream Smad signalling molecules and 
b) phosphorylation of TGF-β receptors, which is a trigger for the initiation and 
transmission of signals from transmembrane receptors to the nucleus. In eukaryotes, 
phosphorylation occurs on serine, threonine, and tyrosine residues, where 
phosphorylation on serine and threonine residue is far more abundant than 
phosphorylation on tyrosine residues (Hunter, 1998). The aims of this study, 
therefore, were as follows:  
1) to identified proteins that are subjected to nuclear-cytoplasmic translocation in 
response to TGF-β stimulation. 
 2) to identified proteins that are subjected to phosphorylation in response to  
TGF-β stimulation. 
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3 MATERIALS AND METHODS 
 
3.1 MATERIALS 
3.1.1 Equipments  
 
Table 2. Laboratory equipments  
 
Equipment Company 
Cell Culture Incubator; Cytoperm2 Heraeus, Germany 
Developing machine; X Omat 2000 Kodak; USA 
Electrophoresis chambers Bio-Rad, USA 
Fluorescence microscope; LEICA AS 
MDW 
Leica, Germany 
Freezer -20 °C Bosch, Germany 
Freezer -40 °C Kryotec, Germany 
Freezer -80 °C Heraeus, Germany 
MALDI-TOF-TOF Bruker Daltonics, Germany 
Protean IEF cell Bio-Rad, USA 
Fridge +4 °C Bosch, Germany 
Mini spin centrifuge Eppendorf, Germany 
Multifuge centrifuge, 3 s-R Heraeus, Germany 
Light microscope; LEICA DMIL Leica, Germany 
Pipetboy Eppendorf, Germany 
Pipetmans: P10, P20, P100, P200, P1000 Gilson, France 
Power Supply; Power PAC 300 Bio-Rad, USA 
Western Blot Chambers: Bio-Rad, USA 
Mini-Protean 3 Cell Bio-Rad, USA 
Vortex machine Eppendorf, Germany 
Film cassette Sigma-Aldrich, Germany 
Filter Tip FT: 10, 20, 100, 200, 1000 Greiner Bio-One, Germany 
Filter units 0.22 µm syringe-driven Millipore, USA 
Glass bottles: 250, 500, 1000 ml Fisher, Germany 
Pipette tip 10, 200, 1000 µl Gilson, USA 
Radiographic film X-Omat LS Sigma-Aldrich, Germany 
FX scanner Bio-Rad, USA 
Serological pipette: 50 ml Falcon, USA 
Test tubes: 15, 50 ml Greiner Bio-One, Germany 
Tissue culture chamber slides BD Falcon, USA 
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Tissue culture dish 100, 150 mm Greiner Bio-One, Germany 
Tissue culture flask 75 ml Greiner Bio-One, Germany 
 
3.1.2 General chemicals 
 
Table 3. General laboratory chemicals 
 
Compounds Company 
β-Mercaptoethanol Sigma-Aldrich, Germany 
3 mm Whatman paper Bioscience, Germany 
12% Ready Gel Precast gels Bio-Rad, USA 
Acetic acid Merck, Germany 
Agarose Promega, USA 
Ammonium Persulfate (APS) Promega, USA 
Bradford reagent Bio-Rad, USA 
Bromophenol blue Sigma-Aldrich, Germany 
3-[(3-
Cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) 
Sigma-Aldrich, Germany 
Protease inhibitor cocktail tablets Roche, Germany 
Dithiothreitol (DTT) Promega, USA 
HEPES Sigma-Aldrich, Germany 
Detection reagents ECL western blotting Pierce, USA 
Ethanol Fluka, Germany 
Eythelene diamino tetra acetic acid Promega, USA 
Glycerol Promega, USA 
Iodoacetamide Sigma-Aldrich, Germany 
IPG strips pH 3-10 Bio-Rad, USA 
Isopropanol Merck, Germany 
Methanol Fluka, Germany 
Mineral oil Bio-Rad, USA 
Potassium chloride Meck, Germany 
Protein standards dual colour precision Bio-Rad, USA 
Rotiphorese® gel 30 Roth, Germany 
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Silver stain kit Bio-Rad, USA 
Sodium acetate Sigma-Aldrich, Germany 
Sodium chloride Merck, Germany 
Sodium dodecyl sulfate (SDS) Promega, USA 
Sodium ortho vanadate Sigma-Aldrich, Germany 
Nitro-cellulose membrane Bio-Rad, USA 
Igepal (Nonidet P-40) Sigma-Aldrich, Germany 
Phosphate-buffered saline Laboratories, Austria 
Phosphoprotein enrichment kit Bioscience, Germany 
Pro-Q-Diamond phosphoprotein stain Invitrogen, UK 
SyproRuby Bio-Rad, USA 
Urea Sigma-Aldrich, Germany 
Temed Bio-Rad, USA 
Trifluoroacetic acid Merck, Germany 
Tris Roth, Germany 
Triton X-100 Sigma-Aldrich, Germany 
Tween-20 Sigma-Aldrich, Germany 
 
3.1.3 Cell culture reagents and other laboratory chemicals 
 
Table 4. Cell culture reagents 
 
Compounds Company 
Trypsin-EDTA Laboratories, Austria 
Dulbecco’s modified eagle medium  Gibco BRL, Germany 
TGF-β1 R&D Systems, USA  
Fetal calf serum (FCS) Laboratories, Austria 
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3.1.4 Antibodies 
 
Table 5. Primary antibodies 
 
Catalogue No. Description Company 
SC5286 tubulin Santa Cruz 
SC20681 lamin Santa Cruz 
#07-392 phospho Smad2 Upstate 
SC28726 hnRNP L Santa Cruz 
H00008570-A01 KHSRP Abnova 
Ab10374 hnRNP H Abcam 
ARP 35703-T200 FUBP1 Aviva System Biology 
 
 
Table 6. Secondary Antibodies 
 
Name Description Company 
Mouse horse-radish peroxidase Anti-mouse IgG(H+L) Pierce, USA 
Goat horse-radish peroxidase Anti-goat IgG (H+L) Pierce, USA 
Rabbit horse-radish peroxidase Anti-rabbit IgG (H+L) Pierce, USA 
 
3.1.5 Cell lines and media 
The A549 epithelial cell line (human lung adenocarcinoma) was cultured in 
DMEM medium with 10% (v/v) FCS. The primary human fibroblasts from idiopathic 
pulmonary fibrotic patients and donors were cultured in DMEM medium with 10% 
(v/v) FCS under sub-confluent conditions. The cells were cultivated on 150 mm tissue 
culture plastic dishes (Sarstedt, Newton, NC, USA) at 37 ºC in 5% CO2 environment 
and 98% humidity. 
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3.1.6 Samples from Patients 
Lung tissue biopsies were obtained from six patients with IPF [usual 
interstitial pneumonia (UIP) pattern; mean age 51.3 ± 11.4 years], and six control 
subjects (organ donors, mean age 47.5 ± 13.9 years). The study protocol was 
approved by the Ethics Committee of the Justus-Liebig-University School of 
Medicine (AZ 31/93). Informed consent was obtained from each subject for the study 
protocol. 
 
3.2 METHODS  
3.2.1 Western blotting 
A) Protein isolation from cells/tissues  
Medium was aspirated from the cells, and the cells were washed twice with ice-cold 
1× PBS phosphate-buffered saline (PBS). In the case of tissues, tissue was ground to 
powder under liquid nitrogen and lysed in lysis buffer [20 mM Tris-HCl, pH 7.5, 0.15 
M NaCl, 1% (v/v) Nonidet P-40] containing a mixture of protease and phosphatase 
inhibitors. The lysates were vortexed every 5 min for 40 min and centrifuged at 
13,000 rpm for 15 min. Protein concentration in the supernatant was measured and 
samples were stored at -80 °C. 
B) Preparation of cytoplasmic and nuclear protein extracts 
The human lung epithelial cell line A549 was obtained from the German Microbe and 
Cell Culture Collection (DSMZ, Braunschweig, Germany). Maintained at 37 °C in  
D-MEM/F-12 A549 cells were rinsed twice with ice-cold PBS, scraped in PBS and 
finally collected by centrifugation at 5000 rpm for 4 min at 4°C. Cell lysis was 
performed in ice-cold hypotonic lysis buffer [20 mM HEPES (pH 7.9), 10 mM KCl, 1 
mM EDTA, 1 mM EGTA, 2 mM Na3VO4, 0.2 % (v/v) NP-40, 10 % (v/v) glycerol] 
supplemented with protease inhibitors (Roche, Mannheim, Germany) for 10 min. 
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Nuclear and cytoplasmatic fractions were separated by centrifugation at 5000 rpm for 
5 min at 4 °C. The resulting supernatant (cytoplasmc fraction) was stored at –80°C 
until further analysis. The supernatant was then resuspended in ice-cold hypertonic 
lysis buffer [20 mM HEPES (pH 7.9), 420 mM NaCl, 10 mM KCl, 1 mM EDTA, 1 
mM EGTA, 2 mM Na3VO4, 20% (v/v) glycerol] supplemented with protease 
inhibitors and incubated for 30 min at 4°C. Soluble compounds were then isolated by 
centrifugation at 13,000 rpm for 5 min at 4°C. The resulting supernatant (nuclear 
fraction) was stored at -80°C until further analysis. 
C) Protein seperation by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE)  
The separating gel mixture was poured between two glass plates and allowed to 
polymerise. The stacking gel mixture was poured on the top of separating gel and a 
comb was inserted in to the gel to form the wells (Table 13 and Table 14). The gel 
was run in 1× Laemmli-running buffer [25 mM Tris-Cl pH 8.3, 0.2M glycine and 
0.1% (v/v) SDS] until the desired distance had been reached.  
D) Immunoblot analysis 
After gel electrophoresis, proteins were transferred to a nitrocellulose membrane 
using a Bio-Rad transfer chamber containing transfer buffer [24 mM Tris base, 
193mM glycine, 10% (v/v) methanol]. Transfer was performed at 4°C overnight at 
12V.  
Blots were incubated for 1 h in blocking buffer [5% (m/v) non-fat dry milk powder in 
PBS with 0.1% (v/v) Tween-20] at room temperature. Incubation with the respective 
primary antibodies (1 µg/ml) was performed in blocking buffer for 1 h at room 
temperature. After washing 3 times for 10 min with buffer [PBS 0.1% (v/v) Tween-
20], blots were incubated with the respective horseradish peroxidase (HRP)-labelled 
secondary antibodies at room temperature for 1 h. After washing 3 times for 10 min 
MATERIALS AND METHODS 29
with wash buffer, blots were developed by enhanced chemi-luminescence (Pierce) 
and visualised with Hyperfilm ECL (Kodak).  
To re-probe with another antibody, the blots were stripped with stripping buffer 
[63mM Tris-Cl pH 6.8, 2% (m/v) SDS, 0.8% (m/v) DTT] at 50 °C for 30 min and  re-
probed as described above.  
Table 7. Composition of 10% resolving gels (40 ml) 
 
Component Volume 
Distilled water 15.9 ml 
30% acrylamide mix 13.3 ml 
1.5 M Tris-Cl (pH 8.8) 10 ml 
10% (m/v) SDS 400 µl 
10% (m/v) APS 400 µl 
TEMED 16 µl 
 
 
Table 8. Composition of 4% stacking gels (20 ml) 
 
Component Volume 
Distilled water 13.6 ml 
30% acrylamide mix 3.4 ml 
1.5 M Tris-Cl (pH 6.8) 2.5 ml 
10% (m/v) SDS 200 µl 
10% (m/v) APS 200 µl 
TEMED 20 µl 
 
3.2.2 Two-dimensional gel electrophoresis 
3.2.2.1 Sample preparation and protein solubilisation 
Proteins in the sample must be denatured, disaggregated, reduced and 
solubilised to achieve disruption of molecular interactions in order that each spot 
represents an individual polypeptide (Gorg et al., 2004). Sample solubilisation is 
MATERIALS AND METHODS 30
usually carried out in a buffer containing chaotropes (for example urea and/or 
thiourea), nonionic and/or zwitterionic detergents e.g. Triton X-100 or 3-[(3-
Cholamidopropyl)dimethylammonio]- 1-propanesulfonate (CHAPS), reducing agents, 
carrier ampholytes (CA) and depending on the type of sample or protease inhibitors. 
Enriched cytosolic and nuclear protein fractions were purified with a ReadyPred™ 2-
D Clean Kit (Bio-Rad Labaratories, CA, USA) as per manufacturer’s protocol, in 
order to concentrate proteins from the sample which are too diluted, for higher protein 
loads, prior to solubilisation in rehydration buffer [50 mM DTT, 4 % (m/v) CHAPS, 9 
M urea]. The protein concentration of both protein fractions was determined using 
Quick StartTM Bradford Dye Reagent on a SmartSpecTM 3000 spectrophotometer 
(both Bio-Rad Laboratories, CA, USA). 
3.2.2.2 First dimension: Isoelectric focusing  
Immobilised pH gradient IPG strips were induced by Görg in the eighties 
(Gorg et al., 1988). The IPG can be a linear or nonlinear wide (for example IPG 3-12), 
narrow (for example IPG 4-7) and/or ultra-narrow (for example IPG 4.9-5.3) pH 
range. The IPGs can be cast in different pH ranges between pH 2.5-12. Also in 
different lengths, usually from 7–24 cm. Prior to IEF the IPG dry strips must be 
rehydrated (usually overnight) to their original thickness of 0.5 mm with a rehydration 
buffer containing urea (or alternatively thiourea), nonioninc or zwitterionic detergents 
(for example CHAPS) and CA (Gorg et al., 2004). Sample can be added to 
rehydration buffer (in-gel rehydration) or can be added to the strips before starting 
isoelectric focusing (cup loading). The longer the IPG strip and the narrower the pH 
gradient, the more voltage required to achieve steady state separation for high 
reproducibility (Gorg et al., 2004). Isoelectric focusing was carried out using the 
PROTEAN IEF Cell system (Bio-Rad Laboratories, Munich, Germany). The IPG 
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strips (17 cm; pH 3-10 NL; Bio-Rad Laboratories, Munich, Germany) were 
rehydrated overnight at 50 V with 0.2 % ampholytes pH 3-10 (Bio-Rad, CA, USA). 
The IEF was performed under the following conditions: 250 V, 1h; 500 V, 1h; 750 V 
1h; 1000 V 1h; 2500 V, 1h; 4000 V, 1h; 8000 V, until 60 kVh. The strips were 
maintained at -80°C until further analysis. 
3.2.2.3 Second dimension: Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Prior to second dimension, the strips were equilibrated for 15 min in 10 ml 
equilibration buffer [6 M urea, 0.375 M Tris-HCl (pH 8.8), 2% (v/v) SDS, 20% (v/v) 
glycerol] containing 2% (w/v) DTT and subsequently for 15 min in equilibration 
buffer containing 2.5% (w/v) iodoacetamide. The SDS-PAGE was performed on a 
Protean® II XL system (Bio-Rad, CA, USA) with lab cast 0.75 mm SDS 
polyacrylamide gels (12.5%) for 3.5 h for 1100 Vh. The gels were individually 
stained with 200 mL SyproRuby™ fluorescent stain (Bio-Rad, CA, US) according to 
the manufacturer’s instructions. Gel images were acquired with the Molecular 
Imager™ FX (Bio-Rad, CA, US) using an excitation wavelength of 532 nm and an 
emission wavelength filter of 610 nm. A software-based image analysis was carried 
out for spot detection, matching and quantification using the PDQuest 2D Analysis 
Software (Bio-Rad, CA, USA). Finally, the gels were stained with silver according to 
the method described by Shevchenko et al (Shevchenko et al., 1996).  
Table 9. Composition of 12% gel (40 ml) 
 
Component Volume 
Distilled water 15.4 ml 
30% acrylamide mix 16 ml 
1.5 M Tris-Cl (pH 6.8) 10 ml 
10% (m/v) SDS 400 µl 
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10% (m/v) APS 400 µl 
TEMED 40 µl 
 
3.2.2.4 Gel analysis 
The gels were individually stained with 200 mL Sypro®Ruby fluorescent stain 
(Bio-Rad, Munich, Germany) according to the manufacturer’s instructions. Each 
sample (cytosolic and nuclear) was analyzed three times. All gels were scanned at 
100-µm resolutions using the Molecular Imager™ FX (Bio-Rad, Hercules, CA, USA) 
using an excitation wavelength of 532 nm and an emission wavelength filter of 610 
nm. Gel images were converted into digital TIF files. Spot detection and pattern 
evaluation and normalization was performed using the PDQuest 2D Analysis 
Software (version 7.2, Biorad, Hercules, CA, USA). One non stimulated gel was 
chosen as a master gel. The protein spots were automatically detected and vizually 
checked for undetected or incorrectly detected spots and then matched to their 
corresponding spots in a digitized master gel. Intensity levels were normalized 
between gels by the total quantity in valid spots in gel images. Protein spots with 
significant changes (using student's t-test, P≤0.05) were selected and cut out for 
identification. Finally, the gels were stained with silver according to the method 
described by Shevchenko et al (Shevchenko et al., 1996).  
3.2.3 Tryptic in-gel digest and MALDI TOF MS analysis 
3.2.3.1 Protein identification by peptide mass fingerprinting 
Selected protein spots were excised from the gel. The gel pieces were washed 
alternately three times with 15 µl 10 mM NH4HCO3 and 5 mM NH4HCO3/50% 
acetonitrile. After drying the gel pieces, 2 µl of trypsin solution (33 ng/µl in 10 mM 
NH4HCO3, pH 7.8) was added to digest the proteins for several hours at 37°C.The 
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tryptic peptides were extracted from the gel pieces with 5-10 µl 0.1% (v/v) trifluoro 
acetic acid (TFA) and spotted onto prespotted AnchorChip targets (Bruker Daltonics, 
Bremen, Germany) according to the manufactures instructions. 
The MALDI-TOF mass spectra were recorded on an Ultraflex II TOF/TOF mass 
spectrometer (Bruker Daltonics, Bremen, Germany), operated in the reflectron mode. 
For acquisition of peptide mass fingerprint spectra (PMF, MS), 200 single shot 
spectra were averaged and the peak finding was undertaken using the SNAP 
algorithm. Protein identification was achieved by searching the mass spectra against 
the NCBI human protein database (http://www.ncbi.nlm.nih.gov/), using the external 
search algorithms Mascot™ (version 1.9.03). For PMF spectra, the mass tolerance 
was set at 50 ppm. 
3.2.3.2  Protein identification by peptide sequencing and peptide mass 
fingerprints 
Proteins were identified using Pick ‘n Post Protein identification service 
(Alphalyse, Denmark) essentially as previously described (Mortz et al., 2001; 
Shevchenko et al., 1996). Briefly, gel-excised protein spots were reduced, alkylated 
with iodoacetamide and digested with trypsin. The resulting peptides were 
concentrated on a ZipTip C18 column (Millipore,USA) and eluted onto an anchorchip 
target for analysis on a Bruker Autoflex III MALDI TOF/TOF instrument (Bruker 
Daltonics, Bremen, Germany). The peptide mixture was analyzed in positive reflector 
mode for accurate peptide mass determination and some of the peptides analyzed by 
MS/MS fragmentation for partial peptide sequencing. For acquisition of peptide mass 
fingerprint spectra (PMF, MS), 3000 single shot spectra were averaged and the peak 
finding was undertaken using the SNAP algorithm. Peptide fragmentation spectra 
(PFF, MS/MS) were acquired when possible. The MS and MS/MS spectra were 
combined and used for a Mascot database search (Mascot version 2.1.03) in the NCBI 
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nrdb protein database protein database. For PMF spectra, the mass tolerance was set 
at 60 ppm allowing 1 missed cleavage site. 
3.2.3.3 Phosphoprotein enrichment by phosphate metal affinity chromatography 
Phosphoprotein enrichment was carried out as described in the phosphoprotein 
enrichment kit user manual (BD Biosciences, USA) Briefly, the cells were treated 
with 2 ng/ml of TGF-β1 for 10, 30, 60, 120 minutes and then washed 3 times with 
ice-cold PBS, suspended with 30 µl of solubilisation buffer (buffer A) for each mg of 
cells. The cell pellet was mixed and centrifuged at 13 000 rpm for 20 min at 4°C and 
the supernatant fraction stored at -80°C until use. Total protein extracts from every 
fraction were added to columns, which had been preequilibrated with buffer A for the 
phosphoprotein enrichment. The column was gently agitated with sample at 4°C for 
20 min on a platform shaker to allow the phosphoproteins to bind to a matrix. The 
non-absorbed material (nonphosphorylated protein fraction) was allowed to flow 
through the column. The column was washed 4 times by adding 5 ml buffer A and 
allowing it to flow through the column, and at the same time the first and the last 
fractions were collected. Finally, 1 ml of elution buffer (buffer B) was added to elute 
the adsorbed material (phosphorylated protein fraction). The procedure was repeated 
4 times. 
3.2.3.4 Concentrating and desalting the phosphoprotein fraction 
For 2-DE analysis, phosphorylated proteins (the eluant fraction) was 
concentrated and desalted. This was achieved by reducing the volume of the eluted 
fraction to 500 µl by centrifigation using the Amicon ultra-4-YM-10 ultrafiltration 
column (Millipore, USA) and adding 3 ml of LC-MS water. The procedure was 
repeated 2 times. The concentrated and desalted proteins were purified with a 
ReadyPred™ 2-D Clean Kit according to the user manual (Bio-Rad Labaratories, CA, 
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USA). Protein concentration was determined by the BCA protein assay (Pierce, USA) 
using a SmartSpec™ 3000 spectrophotometer (both Bio-Rad Laboratories, Munich, 
Germany). 
3.2.3.5 Separation of enriched phosphoproteins by two-dimensional 
electrophoresis 
The total phosphoprotein fractions enriched and purified from the cell extracts 
were subjected to IEF, which was carried out using the PROTEAN IEF Cell (Bio-
Rad).The IPG strips (11 cm; pH 3-10 NL) (Bio-Rad) were rehydrated overnight at 
50V with 0.2 % ampholytes pH 3-10 (Bio-Rad, CA, USA). The first dimension was 
performed under the following condition: 1000 V linear for 4 h; 1500 V rapid for 1 h; 
2500 V rapid for 1 h; 4000 V rapid for 1 h; 6000 V rapid untill 35 kVh. The strips 
were maintained in -80°C until use. Prior to running the second dimension, strips 
were equilibrated as described previously (Chapter 3.2.2.3). Criterion™ precast Gels 
12% (Bio-Rad, CA, USA) were used for the second dimension. The gels were fixed 
according to protocol for Pro-Q® Diamond Phosphoprotein Gel Stain in 50% 
methanol and 10% acetic acid, destained by washing 4 times in 50 mM sodium 
acetate, pH 4.0, 4% acetonitril (ACN) (400 ml per gel) for 1 h. Gel images were 
acquired with the Molecular Imager™ FX (Bio-Rad, CA, US). After scaning gels 
were incubated in SyproRuby overnight and scaned with the same software. 
Identification of proteins was carried as described in the section 3.2.2.4. 
3.2.4 Immunofluorescence 
Alveolar epithelial cells were seeded on eight-well chamber slides at 10 X 10³ per 
well and treated as indicated. Cells were then washed with cold PBS and fixed with 
ice-cold methanol for 10 min at -20°C. After washing twice with PBS, slides were 
incubated in blocking buffer [5% (v/v) FCS in 1 × PBS] for 1 h at room temperature 
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followed by an overnight incubation with the primary antibodies at 4°C, as described. 
After washing, incubation with FITC-labelled secondary antibodies, cells were 
washed for 5 times with PBS, the plastic border of the slide was removed and slides 
were covered with mounting medium and a cover slide. Nuclei were visualised by 
4,6-diamidino-2-phenylindole (DAPI) staining and individual cells analysed by 
deconvolution fluorescence microscopy using a Leica AS-MDW miscroscope. 
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4 RESULTS 
4.1 SUBCELLULAR FRACTIONATION 
The classic proteomics approach (analysis of total crude homogenate) may fail 
in the discovery of proteins that are constituent proteins of particular subcellular 
compartments, but minor proteins of the whole crude homogenate. A study by Dreger 
et. al. (Dreger, 2003a) suggested subcellular fractionation prior to MS analysis in 
order to detect and identify proteins of particular subcellular compartments. In this 
study, the classical proteomics approach has been modified. The new strategy based 
on: stimulation of cells at different time points with TGF-β1, performing subcellular 
fractionation, and separating protein fractions by two-dimensional electrophoresis was 
applied (Figure 4.1). Proteins of interest, potential translocoms, have been selected for 
identification. Since Smads, which are downstream molecules of TGF-β signalling 
pathway, translocate into the nucleus within 30 min after stimulation (Nicolas et al., 
2004), cells were stimulated for 30, 60 and 120 minutes with TGF-β. In order to 
separate and enrich nuclear and cytosolic fractions, buffers with different tonicity 
were used. After extracting the cytoplasmic fraction using hypotonic buffers, samples 
were stored at -80°C, the nuclear fraction in the pellet was dissolved in hypertonic 
buffer and after 30 minutes of vortexing, samples were centrifuged and proteins from 
the nuclear fraction, now in supernatant fraction were stored at -80°C. 
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Figure 4.1. Schematic illustration of a strategy to study translocation events. A lung epithelial cell 
line was stimulated with TGF-β at different time points (0, 30, 60, 120 min), after stimulation 
subcellular fractionation was performed. Enriched fractions were separated by two-dimensional gel 
electrophoresis and candidates of interest were identified with mass spectrometry. 
 
Prior to constructing a two-dimensional map of subcellular fractions, regular 
immunoblotting was performed to demonstrate enrichment of nuclear and cytosolic 
fractions after TGF-β1 stimulation in time-dependent manner. The protein α-tubulin 
was used as a cytosolic marker and lamin A/C and phosphoSmad2 were used as a 
nuclear marker in both control and TGF-β stimulated cells. Using hypertonic and 
hypotonic buffers it was possible to enrich cytosolic and nuclear fractions as 
illustrated in Figure 4.2. In addition, due to an increase in pSmad2 phosphorylation it 
can be concluded that stimulation with TGF-β1 was successful. Faint bands of lamin 
A/C were observed in the cytosolic fraction. Subcellular fractionation enriches certain 
cellular compartments but does not achieve complete separation which may be why 
some traces of lamin A/C present in cytoplasmic fraction. In fact, according to 
immunoblots against pSmad2, α-tubulin and lamin A/C cytosolic and nuclear 
fractions were enriched and further study could be carried on. 
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Figure 4.2. Subcellular fractionation of A549 cells. Subcellular fractions, cytosolic (CF) and nucler 
(NF), were subjected to immunoblot analysis with antibodies against α-tubulin (marker for cytosolic 
fraction), lamin A/C, and pSmad2 (markers for TGF-β stimulation and nuclear fraction respectivly) 
after TGF-β stimulation at different time points. 
 
4.2 TWO-DIMENSIONAL SEPARATION OF CYTOPLASMIC AND 
NUCLEAR PROTEIN FRACTIONS FROM A549 CELL LINE 
The TGF-β1 ligand starts signaling by binding to and bringing together type I 
and type II receptor serine/threonine kinases on the cell surface, which than trigger 
events inside the cell. Signalling is initiated by ligand-receptor binding at the cell 
membrane, which causes activation (phosphorylation) of the receptor and which in 
turn transduces the signal to the cytoplasmic proteins. In this study, cytosolic and 
nucear fractions were analysed with a focus on activated receptors and Smads 
interactions inside the cytoplasm. Two-dimensional electrophoretisis (2-DE) maps of 
nuclear and cytosolic fractions are illustrated in Figure 4.4. According to the result 
shown in Figure 4.2, maximal accumulation of pSmad2 in the nucleus occurred after 
2 h, therefore 2-DE was carried out with enriched protein fractions, which had been 
stimulated with TGF-β1 for 2 h and for the control samples (those without 
stimulation). Proteins were visualized with SyproRuby followed by silver staining. 
Image analysis using PDQuest Image Analysis software. Among the resulting protein 
spots, only those with a fold change > 1.5 was selected for further analysis. A typical 
2-DE analysis with the software, and quantification of proteins stained with 
SyproRuby dye (control samples and samples stimulated for 2 hours with TGF-β) is 
illustrated in Figure 4.5. Some of the protein spots did not show change in quantity 
RESULTS 40
after analysis with the software. This spots were abundant and easily identified and 
were used as a control. 
 
4.2.1 Two-dimensional gel electrophoresis analysis of cytosolic enriched 
fraction 
 As expected, large changes at the proteome level in cytosolic- and nuclear-
enriched fractions, after cell stimulation with TGF-β (Figure 4.3), were not observed 
(Figure. 4.4). After analysis with PDQuest software 260 spots have been detected on 
both gels. A group of spots of basic pI and molecular mass between 60-80 kDa were 
detected only in the cytosolic fraction obtained from cells stimulated with TGF-β1 
(spots 3, 4, 5, 6, 7 and 11; Figure 4.4, Table 10). In addition, some protein spots (spot 
16, 17, 18, and 19) of acidic pI were more intense in control samples in comparison 
with stimulated samples. Several spots (spots 9, 10, 14, and 15) were excised and 
served as a control. 
.  
Figure 4.3. Control of subcellular fractionation of A549 cells after 120 minutes TGF-β 
stimulation. Prior to two dimensional separation of subcellular fractions immunoblotting-control 
experiments were performed against cytoplasmic (α-tubulin), nuclear (lamin A/C) and TGF-β1 
stimulation (pSmad2) markers (CF-cytosolic fraction, NF-nuclear fraction). 
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Figure 4.4. Two-dimensional separation of cytoplasmic and nuclear fractions. The Proteins were 
separated by 2-DE (first dimension, 11 cm 3-10 IPG strips, second dimension 12 % SDS PAGE) and 
visualised by Sypro®Ruby. The 18 annotated spots are labelled from the cytoplasmic fraction and 19 
from the nuclear and corresponding identifications were made by MS and MS/MS as reported in Table 
1 and 2. 
 
The group of 19 protein spots was excised from the gels with enriched cytosolic 
fraction and a tryptic digest was preformed, proteins were identified by MS or MS/ 
MS. From 19 picked protein spots 18 could be identified (Table 10). 
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Table 10. Identified proteins from cytoplasmic fraction 
Spot 
(#) 
GI-
number Protein 
Mascot 
Score 
TGFβ/ 
control ± 
s.d
Sequence 
coverage Peptides identified by MS/MS 
1 5729877 
Heat shock 
70kDa protein 
8 isoform 1 
336 2.26±1.82 40% 
138TVTNAVVTVPAYFNDSQR155
160DAGTIAGLNVLR171 
300ARFEELNADLFR311 
302FEELNADLFR311
2 12653415 
Heat shock 
70kDa protein 
9B 
367 1.12±1.01 30% 
188NAVITVPAYFNDSQR202 
349AQFEGIVTDLIR360
499LLGQFTLIGIPPAPR513
3 54648253 KHSRP 238 0.40±0.44 47% 
123LASQGDSISSQLGPIHPPPR142
321IGGGIDVPVPR331 
395SGPPGPPGGPGMPPGGR411
449AINQQTGAFVEISR462
4 4501867 Aconitase 2 precursor 362 0.29±0.45 36% 
69IVYGHLDDPASQEIER84
412SQFTITPGSEQIR424
634NAVTQEFGPVPDTAR648
5 17402900 
Far upstream 
element-
binding protein 
142 0.77±1.06 40% 
272IGGNEGIDVPIPR284
309IQFKPDDGTTPER321
6 37078490 
Far upstream 
element-
binding protein 
195 0.25±0.44 45% 
271IGGNEGIDVPIPR283 
308IQFKPDDGTTPER320
7 46812638 hnRNP-L 115 0.55±0.85 33% 
67TPASPVVHIR76
404AITHLNNNFMFGQK417
8 189998 M2-type pyruvate kinase 366 1.24±0.656 65% 
44NTGIICTIGPASR56
74LNFSHGTHEYHAETIK89
279RFDEILEASDGIMVAR294
384EAEAAIYHLQLFEELRR400
9 62896593 Enolase 1 variant 311 1.14±0.54 47% 
33AAVPSGASTGIYEALELR50
240VVIGMDVAASEFFR253
10 21361176 
Aldehyde 
dehydrogenase 
1A1 
377 0.53±0.19 33% 
144TIPIDGNFFTYTR156 
379GYFVQPTVFSNVTDEMR395
396IAKEEIFGPVQQIMK410
421ANNTFYGLSAGVFTK435 
477ELGEYGFHEYTEVK490
11 5031753 hnRNP-H1 201 0.43±0.43 52% 
99HTGPNSPDTANDGFVR114 
263DLNYCFSGMSDHR275 
317VHIEIGPDGR326
12 21361657 PDIA3 410 1.138±0.402 42% 
336FVMQEEFSR344
352FLQDYFDGNLKR363
449GFPTIYFSPANK460
472ELSDFISYLQR482
13 38327502 CArG binding factor 159 0.32±0.32 43% 
41DLTEYLSR48
49FGEVVDCTIK58
68GFGFVLFK75
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(Continuation of Table 10. from page 42) 
 
Spot 
(#) 
GI-
number Protein 
Mascot 
Score 
TGFβ/ 
control ± 
s.d
Sequence 
coverage Peptides identified by MS/MS 
14 99893 Triosephosphate isomerase 233 1.10±0.37 73% 
33VPADTEVVCAPPTAYIDFAR52
99RHVFGESDELIGQK112
100HVFGESDELIGQK11
15 30354488 PDI-related protein 93 0.63±0.37 33% 
355GSFSEQGINEFLR367 
374GSTAPVGGGAFPTIVER390
16 34234 Laminin-binding protein 317 0.62±0.80 50% 
54AIVAIENPADVSVISSR70
93FTPGTFTNQIQAAFR107
17 57997573 Hypothetical protein 428 1.49±0.2 40% 
13KIQVLQQQADDAEER27 
55RIQLVEEELDR65
112KLVIIEGDLER126
18 4507651 Tropomyosin 4 275 1.1±0.49 46% 
55RIQLVEEELDR65 
56IQLVEEELDR69
Some of the identified proteins (spot 1, 2) are involved in binding to nascent 
polypeptides to facilitate correct folding. It is well know that TGF-β signalling 
regulates the rate of protein synthesis. Studies from Takenaka et. al.(Takenaka and 
Hightower, 1993) reported the rapid induction of HSP70 and HSP90 protein family 
members within first 5h of TGF-β1 treatment. It is possible that in preparation for 
increased rates of protein synthesis after stimulation with growth factors, the cell 
produces more heat shock chaperone proteins (HSPs) to modulate the newly 
synthesized proteins. The TGF-β ligand can activate p38 MAPK (Seay et al., 2005). 
Protein spot 3 identified as, K-homology type splicing regulatory protein (KHSRP), 
an important factor for AU-rich element (ARE)-directed mRNA decay, undergoes 
p38-dependent phosphorylation during muscle differentiation. Furthermore, KHSRP 
phosphorylated by p38 displays compromised binding to ARE-containing transcripts 
and fails to promote their rapid decay (Briata et al., 2005). Protein spots 5 and 6 were 
identified as far upstream element-binding protein (FUBP1); TGF-β induced p38 
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expression and promoted its translocation to nuceus for the regulation of FUBP1 and 
c-myc (Kim et al., 2003). The hnRNPs are RNA binding proteins (protein spot 7, 11) 
and they perform complex with heterogeneousnuclear RNA (hnRNA). These proteins 
are associated with pre-mRNA in the nucleus and appear to influence pre-mRNA 
processing and other aspects of mRNA metabolism and transport. While all of the 
hnRNPs are present in the nucleus, some seems to shuttle between the nucleus and the 
cytoplasm (Pinol-Roma and Dreyfuss, 1992). Signalling by TGF-β stimulates activity 
of glycolytic enzymes (Roy and Terada, 1999). Spots 4 and 8 represent aconitase 2 
and M2-type pyruvate kinase, respectively. This suggests that TGF-β can also 
promote trafficking of glycolytic proteins, and such observations may provide insight 
into the molecular mechanism of TGF-β action in glycolytic processes. Three novel 
proteins without assigned function were also been identified (protein spots 13, 16, 
18). Thus, we identified translocated proteins involved in diverse activities such as 
protein folding, transcriptional activation, mRNA metabolism and transport. 
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B)
A) 
C) 
Figure 4.5. Alterations in protein profiles between cytosolic fractions from stimulated cells and 
unstimulated controls. Separation of cytosolic enriched proteome stimulated with TGF-β1 (2ng/mL) 
or unstimulated controls with two-dimensional gel electrophoresis (A). Magnification of a 2-DE zone 
stained with SyproRuby (B) (CF-cytosolic fraction). Master map at the bottom depicts spots, which 
were detected on both gels (stimulated and control gels) and the difference in spot quantity between 
conditions(C). 
 
4.2.2 Validation of the translocation data 
In order to validate our proteomic data (the enrichment of subcellular 
fractionation combined with proteomic analysis), we preformed immunoblotting and 
immunofluorescence with antibodies specific for selected identified proteins. 
Antibodies to some of the proteins were commercially available, including FUBP1, 
KHSRP, hnRNPL, hnRNPH. Activation of downstream TGF-β signaling molecules 
(Smads) and their accumulation in the nucleus occurs within 30 minutes (Nicolas et 
al., 2004). Therefore, A549 cells, were stimulated for 30 min, 1 h, and 2 h, subjected 
to immunobloting with antibodies against KHSRP (spot 3), FUBP1 (spot 6), hnRNP 
L (spot 7), hnRNP H (spot 11) (all identified using a proteomic approach). 
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Translocation of KHSRP from nucleus started after 30 min and was time-dependent 
(as illustrated in Figure 4.6). The increased accumulation of KHSRP was detected 
after 30 min and occured in a time-dependent manner after TGF-β1 stimulation. 
 
Figure 4.6. Translocation of KHSRP, FUBP1, hnRNP H, hnRNP L in A549 cells after TGF-β1 
stimulation. The A549 cells were stimulated with TGF-β1 (2 ng/ml), after which subcellular 
fractionation (CF-cytosolic fraction, NF-nuclear fraction) and immunoblot analysis were preformed. 
 
Using an immunofluorescence assay, KHSRP was detected to be localized in the 
nucleus and the cytoplasm. After stimulation with 2 ng/ml of TGF-β1, localisation of 
the KHSRP protein was evident predominantly in the cytoplasm (Figure 4.7). 
The FUBP1 was translocated from nucleus after 2 h and increased signal was 
observed in enriched cytoplasmic fractions; according to the nuclear fraction, 
translocation was not complete (Figure 4.6); the hnRNP H translocation was 
confirmed by immunoblotting within 30 minutes stimulation with TGF-β1. The 
hnRNP L was depleted from nuclear-enriched fractions after 2 h stimulation with 
TGF-β1 and translocation was confirmed by immunoblotting and 
immunofluorescence assay (Figures 4.6 and 4.7). Thus, the identities of translocating 
proteins were established by mass spectrometry and were confirmed by 
immunoblotting and/or immunofluorescence assays. 
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Figure 4.7. TGF-β1-dependent translocation of hnRNP L, FUBP1 and KHSRP. The A549 cells 
were plated on glass slides, treated as indicated and localisation of translocoms assessed by 
immunofluorescence analysis. All the translocoms were detected by fluorescein isothiocyanate (FITC)-
labeled secondary antibody and nuclei were visualised by 4, 6-diamidino-2-phenylindole staining. 
 
4.2.3 Two-dimensional gel electrophoresis analysis of nuclear enriched fraction 
The enriched nuclear proteome is illustrated in Figure 4.3. After analysis with 
PDQuest software 321 spots have been detected on both gels. According to software 
analysis, 19 spots exhibited significant differences in quantity of signal and were 
selected for further analysis. After excision from the gel and in-gel tryptic digestion, 
proteins from the nuclear fractions were identified (Table 11). From 19 selected spots, 
13 were identified. Protein spots 1, 3, 5, 15, 16, 17, 19 were not identified by the 
MASCOT program, perhaps because: the amount of sample was too low for 
identification or the peptide mass fingerprints with sound spectra did not match with 
the protein database. Some of the identified proteins in the nuclear fraction have 
reported roles in the nucleus (spots 2, 6, 11). Spots 10, 12, 13 and 14 belong to the 
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tropomyosin family of proteins. Isoforms of tropomyosin-1 were identified in spots 12 
and 14. Protein spots 4, 8, 18 were identified like 3-hydroxyisobutyryl-Coenzyme A 
hydrolase, Chain A, hCG2017792 isoform CRA_b. These proteins have only been 
detected until now at the transcript level and this is the first time that were detected at 
the protein level. Protein spot 9 was identified as reticulocalbin, a member of CREC 
family of proteins primary localised in endoplasmatic reticulum. Protein spot 7 was 
identified as triosephosphate isomerase and was reported to be regulated at the protein 
level by TGF-β stimulation in human fibroblast (Berns et al., 2004; Bratt et al., 2001). 
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Table 11. Translocated proteins identified in nuclear fraction  
 
Spot 
(#) 
GI-
number 
NAME OF 
PROTEIN 
Mascot
Score 
TGF-
β/Control 
± s.d.) 
Sequence 
coverage Peptides identified by MS/MS 
2 16241370 
myc far 
upstream 
elementbinding 
336 0.62±0.2 38%
138TVTNAVVTVPAYFNDSQR155 
160DAGTIAGLNVLR171 
300ARFEELNADLFR311 
302FEELNADLFR311
4 
119631278 
 
Coenzyme A 
hydrolase 367 0.49±0.11 
24%
188NAVITVPAYFNDSQR202 
349AQFEGIVTDLIR360
499LLGQFTLIGIPPAPR513
6 74735411 CPSF5 238 n.d 34%
123LASQGDSISSQLGPIHPPPR142 
321IGGGIDVPVPR331 
395SGPPGPPGGPGMPPGGR411
449AINQQTGAFVEISR462
7 39932641 
triosephosphate 
isomerase 362 1.29±0.19 
22%
69IVYGHLDDPASQEIER84
412SQFTITPGSEQIR424
634NAVTQEFGPVPDTAR648
8 14488599 Chain A 142 0.69±0.1 20%
272IGGNEGIDVPIPR284
309IQFKPDDGTTPER321
9 2493462 reticulocalbin 1 195 2.53±0.95 29%
271IGGNEGIDVPIPR283 
308IQFKPDDGTTPER320
10 136090 
beta 
tropomyosin 115 n.d
 18%
67TPASPVVHIR76
404AITHLNNNFMFGQK417
11 4503477 EF-1-beta 366 1.28±0.22 24%
44NTGIICTIGPASR56
74LNFSHGTHEYHAETIK89
279RFDEILEASDGIMVAR294
384EAEAAIYHLQLFEELRR400
12 136092 
skeletal muscle 
tropomyosin 201 0.43±0.21 
22%
99HTGPNSPDTANDGFVR114 
263DLNYCFSGMSDHR275 
317VHIEIGPDGR326
13 24119203 
tropomyosin 3 
isoform 2 410 n.d
 39%
336FVMQEEFSR344
352FLQDYFDGNLKR363
449GFPTIYFSPANK460
472ELSDFISYLQR482
14 89954539 tropomyosin 1 159 n.d 32%
41DLTEYLSR48
49FGEVVDCTIK58
68GFGFVLFK75
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4.3 NEWLY IDENTIFIED PHOSPHOPROTEINS IN TGF-β SIGNALLING 
PATHWAY 
4.3.1 Purification of phosphoproteins 
Protein phosphorylation plays an important role in various cellular processes 
such as cell division, metabolism, survival and apoptosis. It is driven by a balanced 
interplay between phosphatases and tyrosine and serine-threonine protein kinases. In 
order to identify novel phosphorylated proteins after stimulation with TGF-β ligand, 
A549 cells were cultured in 1% FCS over 24 h and then stimulated for 1 h with TGF-
β1 concentration 2ng/mL. After stimulation, cells were harvested, and proteins were 
extracted. As phosphorylated proteins are of a relatively low abundance in the cell in 
comparison to the total proteome, it was necessary to perfrom phosphoprotein 
enrichment prior to MS analysis (Pandey et al., 2000). For enrichment of 
phosphoproteins, a commercially available phosphor metal affinity chromatography 
(PMAC) was employed (Figure 4.8).  
 
Figure 4.8. The phosphoprotein enrichment procedure. Extraction/Loading Buffer contains a mild, 
non-ionic detergent for efficient, non-denaturing extraction of cellular proteins. 
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Figure 4. 9. Complete separation of non-phosphorylated and phosphorylated proteins. 
Phosphoprotein affinity column was loaded with 8 mg of protein extracted from A549 cells. Cell 
extracts were divided into numerous fractions including total extract, flowthrough, first wash, last 
wash, and eluant. The α-tubulin, and pSmad2 were used as a control for immunodetection of enriched 
non-phosphorylated and phosphorylated proteins respectively. 
 
Protein extracts from A549 cells stimulated with TGF-β1 or control (non-stimulated 
cells) were separated into flowthrough, first wash, last wash, and eluant fractions by 
PMAC. Both pSmad2 and α-tubulin were used as a control for phosphoprotein 
enrichment. In a total cell extracts, pSmad2 and α-tubulin were deceted (Figure 4.9). 
Decreased amounts of pSmad2 were observed in flowthrough fractions, indicating 
some loss of phosphoproteins after phosphoproteome enrichment with a commercially 
available enrichment kit. The absence of non-phosphorylated α-tubulin in the eluant 
fraction (which is enriched with phosphorylated proteins) and presence of pSmad2 in 
the eluant demonstrated the effective separation of phosphorylated proteins from non-
phosphorylated proteins using PMAC (Figure 4.9). Therefore, we could purify and 
enrich phosphorylated proteins from cellular extracts. Since Pro-Q Diamond binds 
exclusively to phosphoryl groups of phosphotyrosine, phosphoserine and 
phosphothreonine in phosphoproteins (Patton, 2000), it was used as a detection 
reagent. The gel was visualizated with Pro-Q Diamond to detect phosphoproteins and 
the same amount of sample was loaded to the gel that was stained with SyproRuby to 
detect total proteins (Figure 4.10). The amount of cellular phosphoproteins was 
increased in A549 cells stimulated with TGF-β1 compared with the unstimulated 
control samples after 10 minutes stimulation with TGF-β. Analysis of phospho 
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proteome induced by TGF-β after 2 and 4 hours of stimulation has been already 
reported (Stasyk et al., 2005) and in this study it was observed increaded 
phosphorylation level after 10 minutes of stimulation. For further analysis, 1 hour 
time point was chosen for stimulation in order to recognize interplay between kinases 
and phosphatases. 
 
Figure 4.10. Phosphoproteome of A549 cells after elution of phosphoproteins from phosphate 
metal affinity chromatography (PMAC) separated by one dimensional gel electrophoresis. After 
stimulation with 2 ng/mL of TGF-β1 0, 10, 20, and 30 min proteins were extracted and the same 
amount of proteins (20 µg) was loaded to the gel. Phosphoproteins were visualized with Pro-Q 
Diamond and the total proteome was visualised with SyproRuby. 
4.3.2 Analysis of total phosphoprotein using two-dimensional electrophoresis 
It was previously demonstrated that TGF-β, can activate other signaling 
pathways like MAPKs (ERK1/2, p38 and c-Jun N-terminal kinase (JNK) pathways 
(Javelaud and Mauviel, 2005; Yue and Mulder, 2000). In addition to the Smads the 
number of phosphoproteins induced by TGF-β is still unclear. To address this 
question, PMAC-enriched phosphoprotein fractions isolated from cells that were 
either unstimulated or stimulated with TGF-β were separated on a 2-DE gel. The 
same gels were visualized with ProQ-Diamond (data not shown) and later with the 
SyproRuby (Figure 4.11) staining. The PDQuest 6.0. software was used to normalize 
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the total amount of protein. The protein spots detected were mainly located in the pI 
range of 4–7, which was consistent with the fact that phosphorylated proteins are 
usually acidic proteins, due to the addition of one or more phosphate groups. Spots 
differently induced by TGF-β1 were scored when they were greater than two-fold 
elevated on SyproRuby-stained gels or if protein spots showed up in a multiple 
pattern. That has been observed in three replicate gels from three independent 
experiments. The analysis revealed 35 reproducible protein spots and which were 
subjected to identification (Figure 4.12). 
 
 
igure 4.11. Two-dimensional electrophoretic analysis of A549 cell fractions after selective 
phoprotein enrichment. Proteins (40µg) were applied to a 11 cm pH 3-10 strip for the first-
F
phos
dimension and later proteins were separated by SDS-PAGE. The gels [control (unstimulated) and 60 
min of stimulation with 2n/mL TGF-β1] were stained with SyproRuby. 
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Figure 4.12. Two-dimensional electrophoretic analysis and alignment of phosphorylated proteins 
after stimulation with TGF-β for 60 minutes. A phosphoprotein affinity column was loaded with 8 
mg of total protein. Total enriched phosphoproteins purified from 8 mg of total protein were separated 
by 2-DE with a pI 3–10 gradient after concentrating and desalting: 2-DE gel images of A459 cells 
stimulated with TGF-β1 for 60 min. Proteins spots which showed reproducible difference between two 
conditions, non-stimulated and stimulated with TGF-β (2ng/mL) are assigned in the figure.  
 
4.3.3 Identification of differential phosphoproteins triggered by TGF-β1 
Protein spots detected after Pro-Q Diamond and SyproRuby stained were 
subjected to in-gel tryptic digestion and protein identities were determined by PMF 
and by searching the NCBInr or Swiss-Prot or TrEMBL databases using the 
MASCOT and ProteinProspector programmes. Proteins with low-abundance were 
identified by pooling spots from more than two gels. Out of 35 protein spots detected 
on gels, that showed reproducible differences or remained the same (taken as a 
control), 25 proteins were identified in the enriched fraction from A549 cells and are 
listed in Table 12. Among them, 15 have been reported to be phosphorylated but not 
in response to TGF-β. Here, we report 10 proteins that have not previously been 
described to be phosphorylated. Protein spots identified as: PDI (spot 1), GRP 78 
(spot 2), calreticulin (spot 3), endoplasmin (spot 4), TER ATPase (spot 5) did not 
show any change after stimulation with TGF-β. They were excised from the gel as a 
phosphoprotein controls. Some spots were identified as: PDIA3 (spots 6), keratin, 
type II (spots 17, 27), annexin A2 (spots 12, 13, 14), TCP-1-epsilon (spot 16), TCP-1-
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beta (spot 7). These proteins with the same molecular mass but differing in their pI 
(two spots for the same protein), were previously reported as phosphoproteins but not 
directly involved in TGF-β signalling (Figure 4.12) 
 
Figure 4.12. Two-dimensional electrophoretic analysis of proteins from TGF-β1 stimulated cells 
compared with the non-stimulated control.  Magnification of a 2-DE zone stained with SyproRuby. 
 
4.3.4 Prediction of phosphorylatrion sites 
Eukaryotic proteins contain one or more motif domains for binding of kinases, 
phosphatases and phoshopeptides. They also contain characteristic sequence motifs 
for post-translational modifications such as phosphorylation, glycosylation or binding 
to specific modular domains (Obenauer and Yaffe, 2004). Scansite 
(http://scansite.mit.edu) is a computational tool developed on the basis of 
experimental results of binding and/or substrate information from oriented peptide 
library screening and phage display experiments to develop scoring algorithm that 
predicts protein–protein interactions and sites of phosphorylation (Obenauer et al., 
2003). In this study, Scansite was used to analyse phosphorylated proteins; newly 
found to be triggered by TGF-β1 stimulation. From 25 identified proteins, 15 were 
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already reported to be phosphorylated (spots 1, 2, 4, 5, 6, 10, 11, 14, 17, 18, 19 20, 21, 
23, 25). Six proteins identified as calreticulin (spot 3), glutamate dehydrogenase 1 
(spot 8), TCP-1-eta (spot 9), TCP-1-zeta (spot 22), aldo-keto reductase family 1 
member C1 (spot 24), cathepsin D (spot 28) were comfirmed by Scansite. Only for 
four protein spots: TCP-1-beta (spot 7), proteasome subunit beta type-1 (spot 15), 
TCP-1-epsilon (spot 16), proteasome subunit beta type-2 (spot 26) we could not find 
any current data about their phosphorylation up to now. In conclusion, from 25 
identified proteins only for 4 does not exist in any kind of data as to be 
phosphorylated, in that manner PMAC enrichment colums showed high purification 
specificity of phosphorpoteins. 
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Table 12. Phosphorylated proteins identified by MALDI-TOF-MS 
 
Spot 
number Name of Protein 
Matched 
Peptides 
Accession
Number Coverage 
Mascot 
Score 
1 PDI 18 P07237 40% 197 
2 GRP 78 33 P11021 45% 144 
3 Calreticulin precursor 23 P27797 41% 122 
4 Endoplasmin 34 P14625 35% 118 
5 TER ATPase 24 P55072 45% 150 
6 PDIA3 24 P30101 43% 148 
7 TCP-1-beta 36 P78371 61% 165 
8 Glutamate dehydrogenase 1 38 P00367 60% 300 
9 TCP-1-eta 19 Q99832 37% 131 
10 Pyruvate kinase isozymes M1/M2 25 P14618 46% 103 
11 PDIA6 17 Q15084 38% 77 
12,13,14 Annexin A2 24 P07355 57% 181 
15 Proteasome subunit beta type-1 18 P20618 66% 99 
16 TCP-1- epsilon 14 P48643 30% 93 
17,27 Keratin, type I cytoskeletal 10 14 P13645 22% 69 
18 Keratin, type II cytoskeletal 1 16 P04264 25% 79 
19 Nucleolar phosphoprotein B23 4 P06748 46% 135 
20 Proteasome subunit alpha type-4 10 P25789 35% 56 
21 Single-stranded DNA-binding protein 10 Q04837 62% 60 
22 TCP-1-zeta 14 P40227 30% 68 
23 IMP dehydrogenase 2 14 P12268 28% 146 
24 Aldo-keto reductase family 1 member C1 11 Q04828 30% 53 
25 Alpha-enolase 18 P06733 50% 154 
26 Proteasome subunit beta type-2 12 P49721 39% 116 
28 Cathepsin D precursor 12 P07339 26% 50 
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Table 13. Classification of identified phosphoproteins divided into functional 
categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional category Protein 
ATPs Family transitional endoplasmic reticulum ATPase 
heat shock protein 70 family 78 kDa glucose-regulated protein
heat shock protein 90 family endoplasmin 
T-complex protein subunit 1 zeta
T-compex protein 1 subunit epsilon
T-complex protein 1 subunit eta
TCP-1 chaperonin family 
T-complex protein 1 subunit beta 
enolase family α-enolase
nucleoplasmin family nucleolar phosphoprotein B23 
peptidase A1 family cathepsin D
proteasome subunit beta type-1
peptidase T1B family 
proteasome subunit beta type-2
peptidase T1A family proteasome subunit alpha type 4 
IMPDH/GMPR family IMP dehydrogenase 2 
aldo/keto reductase family aldo-keto reductase family 1 member C1
Glu/Leu/Phe/Val 
dehydrogenases 
family 
 
glutamate dehydrogenase 1
annexin family annexin A2 
protein disulfide-isomerase 
precursor 
protein disulfide-isomerase A6 
protein disulfide isomerase 
family 
protein disulfide-isomerase A3
keratin, type II cytoskeletal 1
intermediate filament family 
keratin, type I cytoskeletal 10
pyruvate kinase family pyruvate kinase isozymes M1/M2 
calreticulin family calreticulin
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5 DISCUSSION 
5.1 TRANSLOCATION IN RESPONSE TO TGF-β STIMULATION 
5.1.1 Analysis of cytoplasmic fraction 
Understanding of TGF-β signalling is of great importance for the in depth 
knowledge of how this factor can regulate cell growth, cell differentiation, 
proliferation and some other cellular processes. In an unstimulated state, R-Smads are 
predominantly cytoplasmic and Smad4 is distributed through out the cytoplasm and 
nucleus. After ligand stimulation, both Smad4 and R-Smads rapidly accumulate in the 
nucleus. One of main features of Smad behaviour is the dynamic nucleo-cytoplasmic 
shuttling that is regulated by a variety of pathways (Reguly and Wrana, 2003). Till 
date, many studies have been performed in order to identify novel interaction partners 
of TGF-β receptors or downstream Smad molecules (Stasyk et al., 2005; Zakrzewicz 
et al., 2007). Here, we describe the combination of subcellular fractionation and a 
proteomic approach as a strategy for the identification of translocation events in the 
cell following TGFβ stimulation.  
Cellular signalling starts at the plasma membrane and continue in the 
cytoplasm. After translocation of Smad molecules to the nucleus, expression of genes 
can be initiated. In order to investigate changes in translocation of intracellular 
proteins after TGF-β stimulation, proteome maps of subcellular fractions were 
determined. The proteome maps were complex, out of a total 260 spots detected under 
various conditions, 22 spots in the cytoplasmic fraction and out of 321 detected spots 
in nuclear fraction, 19 spots in the nuclear fraction were taken for further analysis 
(Figure 4.3).  
Eighteen proteins in the cytoplasmic fraction and nine in the nuclear fraction 
were identified that are known to translocate after TGF-β1 stimulation (Tables, 10 
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and 11). In order to confirm the results obtained with this novel approach, two 
independent methods (immunoblotting and immunofluorescence) were emoloyed 
following translocoms: hnRNP H, hnRNP L, FUPB1 and KHSRP (Figure 4.6 and 
Figure.4.7). The identified translocated proteins fall into several groups with diverse 
activities such as protein folding, transcriptional activation, mRNA metabolism and 
transport. 
The protein FUBP1 binds a pyrimidine-rich sequence in the 3´ UTR 
(untranslated region) of GAP-43 mRNA and has been postulated to modulate stability 
of the transcript (Kim et al., 2003). A FUSE-binding protein was previously identified 
as a sequence specific single- stranded DNA binding protein which targets a far 
upstream cis element (FUSE) of c-myc and stimulates its expression (Liu et al., 2006). 
In proliferating hematopoietic cells, FBP and c-myc mRNA expression have been 
shown to be co-ordinately regulated (Kim et al., 2003; Liu et al., 2006). It is known 
that TGF-β can induce p38 expression and promote its translocation in to nuclei for 
regulation of the FUSE-binding protein and c-myc (Yu et al., 2002), it is highly 
possible that this mechanism of translocation can be directed by p38 MAPK. Heat 
shock proteins (HSPs) can be classified according to their molecular weight into four 
major families, the small molecular weight HSP family, the HSP60 family, HSP70 
family, and HSP90 family (Takenaka and Hightower, 1993). Upon exposure of cells 
to environmental stresses including heat shock, oxidative stress, heavy metals, or 
pathological conditions (such as ischaemia, inflammation, tissue damage, infection, 
and neoplastic transformation) cells respond in rapid increase in HSP expression. 
Recently Mattaj and Englmeier (Mattaj and Englmeier, 1998) reported that HSP70 
promotes the formation and stability of a nuclear localisation signal (NLS) complex 
and regulates the import of proteins into the nucleus. Morimoto (Morimoto, 2002) 
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found that HSP could dynamically remodel transcription complexes. It is thus 
possible that HSP70 helps to facilitate molecular transport between the nucleus and 
cytoplasm in response to TGF-β stimultion. 
hnRNPs are predominantly nuclear RNA-binding proteins that form complexes with 
RNA polymerase II transcripts. These proteins have a broad spectrum of cellular 
functions, from transcription and pre-mRNA processing in the nucleus to cytoplasmic 
mRNA translation (Pinol-Roma and Dreyfuss, 1992). Recent studies have suggested 
that several major characteristics of hnRNPs can explan their involvement in 
regulatory pathways. It has been reported that hnRNP A2/B1 is involved in mRNA 
splicing or mRNA localisation (Pinol-Roma and Dreyfuss, 1992). Yan (Yan et al., 
2006) confirmed that hnRNP directly binds to Smad2 or hnRNP binds to an 
interacting partner of Smad2, so translocation of hnRNP proteins was expected and 
therefore we used it as a positive control in this study (Figure 4.6 and Figure 4.7). 
Aconitase 2 and M2-type pyruvate kinase are predominantly mitochondrial 
proteins. Both of them have been identified to be increased in cytosolic fraction upon 
TGF-β1 stimulation. Study from Shyamal et.al (Roy and Terada, 1999) clearly 
showed that TGF-β modulated activities of pyruvate kinase which is involved in 
glycolysis and Krebs cycle. Mitochondrial translocation of aconitase 2 and pyruvate 
kinase in response to TGF-β1 stimulation can give us better insight into tricarboxylic 
acid cycle and glycolysis and the role of TGF-β signalling in their regulation. 
5.1.2 Analysis of nuclear fraction 
In the nuclear fraction 11 proteins were identified of which eight shuttled from 
the nucleus and three into the nucleus after stimulation with TGF-β. Among 11 
proteins, members of tropomyosin family were identified and all of them according to 
proteomic data translocate from nucleus after TGF-β stimulation. The study by Piek 
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et. al. (de Caestecker et al., 2000) has shown how TGF-β induction of actin stress 
fibers depends on Smad signalling. Tropomyosins play an essential role in TGF-β 
induced stress fiber formation in mouse and human epithelial cell lines (Bakin et al., 
2004). Translocation study of tropomyosin family members can help in better 
understanding of TGF-β regulation of stress fibers and control of cell motility. In this 
study elongation factor 1-beta (EF-1) was identified to be translocated into nucleus 
after TGF-β stimulation. Iborra et. al. showed that 10–15% of cellular protein 
synthesis can occur in the nucleus (Iborra et al., 2001). Some elongation factors can 
obtain their function in the nucleus; EF-1 can be one of the candidates, although 
further analysis are required in support of this hypothesis. Cleavage and 
polyadenylation specificity factor subunit 5 (CPSF5) belongs to nudix hydrolase 
family and is involved in processing of pre-mRNA in the nucleus. In the study from 
Borsi L et. al (Borsi et al., 1990) it is presented that TGF-β may regulate the splicing 
pattern of pre-mRNA and translocation of CPSF5 together with other pre-mRNA 
regulatory proteins which we identified here to translocate in response to TGF-β 
stimulation. This might give us a better overview into implication of TGF-β signaling 
pathway into pre-mRNA processing.  
Moreover, subcellular fractionation combined with proteomic approach gave 
good combination of analytical methods to identify translocated proteins in response 
to TGF-β1 stimulation. With this approach we can get better insight into uncovered 
regulatory processes of TGF-β signalling. The translocoms reported in this study 
could represent new directions to be followed to understand multiple functions of 
these TGF-β signalling. Further studies are required to clarify functional contribution 
of translocoms to TGF-β signalling. 
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5.2 IDENTIFICATION OF NOVEL PHOSPHORYLATED PROTEINS IN 
TGF-β SIGNALLING PATHWAY 
Previously, after stimulation with TGF-β1 from 2 hours up to 4 hours, protein 
phosphorylation level was shown to have a relatively high amplitude of changes 
(Kanamoto et al., 2002), (Stasyk et al., 2005). In this study, A549 cells were 
incubated with TGF-β1 up to 1 hour. Phosphoproteome was enriched and proteins 
phosphorylated in respons to TGF-β stimulation were identified (Tables 12 and 13). 
Activation of TGF-β receptors leads to a large number of intracellular interactions, 
which include different effector molecules. The stimulus can lead to cytoskeletal 
changes, activation of transcription in the nucleus, and ultimately result in cell 
proliferation, differentiation or motility. The TGF-β ligands signal via membrane-
bound heteromeric serine/threonine kinase receptor complexes. Upon ligand binding, 
receptor activation leads to the phosphorylation of cytoplasmic protein substrates of 
the Smad family (Derynck and Feng, 1997). Phosphorylation is one of the most 
important events in TGF-β signalling. 
In this study, phosphoproteome profiling of TGF-β signaling in the lung 
alveolar epithelial cell line A549 was employed to reveal novel regulatory targets of 
TGF-β signalling. Two-dimensional gel electrophoresis and peptide mass 
fingerprinting using MALDI-TOF-MS in combination with phosphoprotein 
enrichment provided reproducible phosphoproteome maps and a high efficiency of 
protein identification (Table 12). It has been selected for identification of 35 
phosphorylated proteins and 25 have been identified. To investigate this issue further, 
PMAC was employed for the enrichment of phosphorylated proteins from the cellular 
extracts (Figure 4.8). Phosphorylated and non-phosphorylated proteins were nearly 
completely separated (Figure 4.9). Phosphorylated proteins were enriched from total 
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proteome and were identified. These results indicated that PMAC can be used as a 
powerful tool to purify and enrich phosphorylated proteins from cellular extracts. 
Most of the protein spots (phosphoproteins) were detected on both gels, sometimes 
the same protein was detected in multiple spots (Figure 4.12). This can be due to 
different phosphorylated isoforms. Other post-translational modifications (including 
glycosylation, sulfation, acetylation and alkylation) are excluded to be present, since 
used fractions in this study phosphoproteins were exclusively purified from the 
cellular extract (Figure 4.9). As confirmed by MALDI-TOF-MS, they were indeed the 
same proteins with different phosphorylation status (Figure 4.12). 
Yue et al.(Yue and Mulder, 2000) described the crosstalk between TGF-β and 
MAPK signalling pathways in in vitro cell models. Downstream targets of receptor 
tyrosine kinases, G-protein-coupled receptors or cytokine receptors also participate in 
the TGF-β signalling network (Derynck and Zhang, 2003). Experimental evidence for 
annexin A2 (spots 12, 13, 14) phosphorylation by pp60src was demonstrated in HEK 
293 cells (Deora et al., 2004). Annexin A2 can also be phosphorylated after the 
activation of other membrane-associated kinases, for example insulin-like growth 
factor 1 and PDGF in CHO cells (Biener et al., 1996). Some studies have previously 
reported that TGF-β could activate PKC (Yakymovych et al., 2001). It can be 
hypothesised that phosphorylation of annexin A2 might be mediated by TGF-β via 
PKC.  
The subunits of chaperonin containing TCP1 were identified from two-dimensional 
electrophoretic analysis in protein spots 7, 9, 16 and 22. It is known that TCP-1 
chaperonin family of proteins play a role in the folding of some structural proteins 
like actin and tubulin. Previous studies have indicated that these proteins have a 
higher level of tyrosine phosphorylation in-stress induced conditions (Kim et al., 
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2002). Berns et al. (Berns et al., 2004) used siRNA bar-code screens to identify TCP-
1-beta as a downstream target of the p53 signaling pathway, indicating that members 
of thise protein family might be involved in the p53 pathways and indicating direct or 
indirect involvement of TGF-β in p53 signalling. Heat shock proteins [endoplasmin 
(spot 4) and GRP-78 (spot 2)] and protein-disulfide isomerase [PDI (spot 1)] were 
identified as a substrate for Akt signalling (Laugesen et al., 2006). In addition, HSPs 
change their phosphorylation in MCF-7 cells under stimulation with TGF-β1 within 
24 hours (Stasyk et al., 2005). In this study both identified HSPs were detected not to 
change their phosphorylation up to one hour of stimulation with TGF-β; together with 
TER ATPase (spot 5), calreticulin (spot 3) and PDI (spot 1) they were cut out to be 
identified as a control for phosphorproteins. The biological significance of HSP 
phosphorylation induced by TGF-β after one hour of stimulation was not examined in 
the present study but phosphorylation of these proteins can regulate interaction with 
other chaperones and intracellular proteins. Protein-disulfide isomerases identified in 
this study [PDIA3 (spot 6), PDIA6 (spot 11)] are known to localize mainly in 
endoplasmatic reticulum, their role is to catalyze the -S-S- bonds in proteins. 
Phosphorylation sites on PDIA6 has been already identified (Beausoleil et al., 2006) 
and some members of PDI family has been described to play a role of a substrate in 
Akt signalling (Barati et al., 2006), what kind of role thise proteins play in TGF-β 
signalling up to now has not been explained. 
The proteins that are components of the cytoskeleton and that regulate actin filament 
formation were also identified to alter their phosphorylation: keratin type II (spot 18) 
and keratin 10 type I (spots 17, 27). The TGF-β1 dependent regulation of expression 
of keratin type I and II and alpha-enolase (spot 25) was described in Mv1Lu cells 
(Kanamoto et al., 2002). The study from Stasky el. al (Stasyk et al., 2005) showed 
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keratin type I and keratn type II to change their phosphorylation rate upon TGF-β 
stimulation up to 24 hours in epithelial breast cancer cell line. Additional experiments 
need to be carried out in order to confirm involvement of those proteins in TGF-β 
signalling. Alpha-enolase (spot 25) plays a role in a number of different processes in 
the cell like carbohydrate degradation and glycolysis. Phosphorylation sites of it has 
been described in a human embryonic kidney 293T cells on TYR-57 and SER-63 
(Kalume et al., 2003). These findings suggest the involvement of TGF-β signalling as 
a potential stimulus for induced tyrosine and serine phosphorylation. 
As it has been expected in this study protein kinase was identified as phosphorylated 
protein: pyruvate kinase isozymes M1/M2 (spot 10). Protein spot 15 (proteasome 
subunit beta type-1), spot 20 (proteasome subunit alpha type-4) and spot 26 
(proteasome subunit beta type-2) were identified as the members of peptidase T1B 
and T1A family. The proteasome contains at least 15 non identical subunits which 
form a highly ordered ring-shaped structure and role of phosphorylation of this 
subunits has not been very well understood. Induction of phosphorylation via TGF-β 
can give us new insight into TGF-β regulation of proteosomal degradation. Glutamate 
dehydrogenase (spot 8) and IMP dehydrogenase 2 (spot 23) are also identified in this 
study as a phosphoproteins. These are already known phosphoproteins; in this study 
their phosphorylation pattern changed after stimulated with TGF-β. Both of the 
proteins were detected on non-stimulated and stimulated phosphoprotein profiles as 
expected. Single-stranded DNA-binding protein (spot 21) located in mitochondrion, it 
binds ss-DNA and is involved in mitochondrial DNA replication and is also know to 
be phosphorylated. Direct or indirect implication of TGF-β signalling into 
mitochondrial replication still remain unclear.  
 
DISCUSSION 67
Phosphorylation triggered by TGF-β (on direct or indirect way) combinaed with 
known functions of proteins in the cell can help us in a better understanding of the 
cellular signalling. 
The detected phosporylated proteins on two-dimensional gels were identified 
based on the peptide mass fingerprint of the PMAC flow-through fraction with the 
high peptide coverage. Despite the limits of two-dimensional analysis to detect 
proteins of low abundance, this method in combination with enrichment procedures 
could be useful to characterise changes in the phosphoproteome under TGF-β 
stimulation.  
  It is necessary to further define the role of the proteins identified in the present 
study in the signalling pathways triggered by TGF-β1. Results from this study have 
revealed many previously unidentified signalling molecules or targets of signalling 
pathways triggered by TGF-β. In conclusion, regulatory functions of TGF-β 
signalling are broader than previously thought. 
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